
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS) - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59AE4A925F0AA33AAE4A004B829455.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ehj">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8825236/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="European Heart Journal">
<meta name="citation_title" content="Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)">
<meta name="citation_author" content="Thibaud Damy">
<meta name="citation_author_institution" content="Referral Center for Cardiac Amyloidosis, Department of Cardiology, Mondor Amyloidosis Network, GRC Amyloid Research Institute, Clinical Investigation Center 006, DHU A-TVB INSERM U955 all at CHU Henri Mondor, UPEC, Créteil, France">
<meta name="citation_author" content="Arnt V Kristen">
<meta name="citation_author_institution" content="Department of Cardiology, Amyloidosis Center, Heidelberg University, Heidelberg, Germany">
<meta name="citation_author" content="Ole B Suhr">
<meta name="citation_author_institution" content="Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Mathew S Maurer">
<meta name="citation_author_institution" content="Columbia University College of Physicians and Surgeons, New York, NY, USA">
<meta name="citation_author" content="Violaine Planté-Bordeneuve">
<meta name="citation_author_institution" content="Department of Neurology, Mondor Amyloid Network, Inserm U955-Team10, East Paris University Hospital Henri-Mondor, France">
<meta name="citation_author" content="Ching-Ray Yu">
<meta name="citation_author_institution" content="Pfizer Inc, New York, NY, USA">
<meta name="citation_author" content="Moh-Lim Ong">
<meta name="citation_author_institution" content="Pfizer Inc, New York, NY, USA">
<meta name="citation_author" content="Teresa Coelho">
<meta name="citation_author_institution" content="Department of Neurosciences, Hospital de Santo António, Centro Hospitalar do Porto, Porto, Portugal">
<meta name="citation_author" content="Claudio Rapezzi">
<meta name="citation_author_institution" content="Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy">
<meta name="citation_author" content="THAOS Investigators">
<meta name="citation_publication_date" content="2019 Apr 1">
<meta name="citation_volume" content="43">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="391">
<meta name="citation_doi" content="10.1093/eurheartj/ehz173">
<meta name="citation_pmid" content="30938420">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8825236/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8825236/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8825236/pdf/ehz173.pdf">
<meta name="description" content="Transthyretin amyloidosis (ATTR amyloidosis) is a heterogeneous disorder with cardiac, neurologic, and mixed phenotypes. We describe the phenotypic and genotypic profiles of this disease in continental Western Europe as it appears from the ...">
<meta name="og:title" content="Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Transthyretin amyloidosis (ATTR amyloidosis) is a heterogeneous disorder with cardiac, neurologic, and mixed phenotypes. We describe the phenotypic and genotypic profiles of this disease in continental Western Europe as it appears from the ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8825236/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8825236">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1093/eurheartj/ehz173"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ehz173.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8825236%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/8825236/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/8825236/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8825236/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ehj.png" alt="European Heart Journal logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to European Heart Journal" title="Link to European Heart Journal" shape="default" href="http://eurheartj.oxfordjournals.org/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Eur Heart J</button></div>. 2019 Apr 1;43(5):391–400. doi: <a href="https://doi.org/10.1093/eurheartj/ehz173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1093/eurheartj/ehz173</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Eur%20Heart%20J%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur%20Heart%20J%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur%20Heart%20J%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Eur%20Heart%20J%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Damy%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Thibaud Damy</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Thibaud Damy</span></h3>
<div class="p">
<sup>1</sup>Referral Center for Cardiac Amyloidosis, Department of Cardiology, Mondor Amyloidosis Network, GRC Amyloid Research Institute, Clinical Investigation Center 006, DHU A-TVB INSERM U955 all at CHU Henri Mondor, UPEC, Créteil, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Damy%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thibaud Damy</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kristen%20AV%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Arnt V Kristen</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Arnt V Kristen</span></h3>
<div class="p">
<sup>2</sup>Department of Cardiology, Amyloidosis Center, Heidelberg University, Heidelberg, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kristen%20AV%22%5BAuthor%5D" class="usa-link"><span class="name western">Arnt V Kristen</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Suhr%20OB%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Ole B Suhr</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Ole B Suhr</span></h3>
<div class="p">
<sup>3</sup>Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Suhr%20OB%22%5BAuthor%5D" class="usa-link"><span class="name western">Ole B Suhr</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maurer%20MS%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Mathew S Maurer</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Mathew S Maurer</span></h3>
<div class="p">
<sup>4</sup>Columbia University College of Physicians and Surgeons, New York, NY, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maurer%20MS%22%5BAuthor%5D" class="usa-link"><span class="name western">Mathew S Maurer</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Plant%C3%A9-Bordeneuve%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Violaine Planté-Bordeneuve</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Violaine Planté-Bordeneuve</span></h3>
<div class="p">
<sup>5</sup>Department of Neurology, Mondor Amyloid Network, Inserm U955-Team10, East Paris University Hospital Henri-Mondor, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Plant%C3%A9-Bordeneuve%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Violaine Planté-Bordeneuve</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20CR%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Ching-Ray Yu</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Ching-Ray Yu</span></h3>
<div class="p">
<sup>6</sup>Pfizer Inc, New York, NY, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20CR%22%5BAuthor%5D" class="usa-link"><span class="name western">Ching-Ray Yu</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ong%20ML%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Moh-Lim Ong</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Moh-Lim Ong</span></h3>
<div class="p">
<sup>7</sup>Pfizer Inc, New York, NY, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ong%20ML%22%5BAuthor%5D" class="usa-link"><span class="name western">Moh-Lim Ong</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Coelho%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Teresa Coelho</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Teresa Coelho</span></h3>
<div class="p">
<sup>8</sup>Department of Neurosciences, Hospital de Santo António, Centro Hospitalar do Porto, Porto, Portugal</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Coelho%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Teresa Coelho</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rapezzi%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Claudio Rapezzi</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Claudio Rapezzi</span></h3>
<div class="p">
<sup>9</sup>Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rapezzi%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Claudio Rapezzi</span></a>
</div>
</div>
<sup>9</sup>; <span class="collab">THAOS Investigators</span><sup>2</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Referral Center for Cardiac Amyloidosis, Department of Cardiology, Mondor Amyloidosis Network, GRC Amyloid Research Institute, Clinical Investigation Center 006, DHU A-TVB INSERM U955 all at CHU Henri Mondor, UPEC, Créteil, France</div>
<div id="aff2">
<sup>2</sup>Department of Cardiology, Amyloidosis Center, Heidelberg University, Heidelberg, Germany</div>
<div id="aff3">
<sup>3</sup>Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden</div>
<div id="aff4">
<sup>4</sup>Columbia University College of Physicians and Surgeons, New York, NY, USA</div>
<div id="aff5">
<sup>5</sup>Department of Neurology, Mondor Amyloid Network, Inserm U955-Team10, East Paris University Hospital Henri-Mondor, France</div>
<div id="aff6">
<sup>6</sup>Pfizer Inc, New York, NY, USA</div>
<div id="aff7">
<sup>7</sup>Pfizer Inc, New York, NY, USA</div>
<div id="aff8">
<sup>8</sup>Department of Neurosciences, Hospital de Santo António, Centro Hospitalar do Porto, Porto, Portugal</div>
<div id="aff9">
<sup>9</sup>Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy</div>
<div class="author-notes p">
<div class="fn" id="ehz173-cor1">
<sup>✉</sup><p class="display-inline">Corresponding author. Tel: +33 1 4981 2253, Fax: +33 1 4981 4224, Email: <span>thibaud.damy@aphp.fr</span></p>
</div>
<div class="fn" id="ehz173-FM2">
<sup>2</sup><p class="display-inline">A full list of THAOS Investigators in Europe is provided in the <a href="#sup1" class="usa-link">Supplementary material online</a>, <em>Appendix</em>.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2018 Feb 13; Revised 2018 Jun 3; Accepted 2019 Mar 11; Collection date 2022 Feb 1.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.</div>
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by-nc/4.0/</a>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC8825236  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30938420/" class="usa-link">30938420</a>
</div>
<div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>See "<a href="https://pubmed.ncbi.nlm.nih.gov/31006018/" class="usa-link">Transthyretin amyloidosis in Western Europe: a snapshot from the THAOS registry and a call for further perspectives.</a>" with doi: 10.1093/eurheartj/ehz205.</div></div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="s1"><h3 class="pmc_sec_title">Aims</h3>
<p>Transthyretin amyloidosis (ATTR amyloidosis) is a heterogeneous disorder with cardiac, neurologic, and mixed phenotypes. We describe the phenotypic and genotypic profiles of this disease in continental Western Europe as it appears from the Transthyretin Amyloidosis Survey (THAOS).</p></section><section id="s2"><h3 class="pmc_sec_title">Methods and results</h3>
<p>THAOS is an ongoing, worldwide, longitudinal, observational survey established to study differences in presentation, diagnosis, and natural history in ATTR amyloidosis subjects. At data cut-off, 1411 symptomatic subjects from nine continental Western European countries were enrolled in THAOS [1286 hereditary (ATTRm) amyloidosis; 125 wild-type ATTR (ATTRwt) amyloidosis]. Genotypes and phenotypes varied notably by country. Four mutations (Val122Ile, Leu111Met, Thr60Ala, and Ile68Leu), and ATTRwt, were associated with a mainly cardiac phenotype showing symmetric left ventricular (LV) hypertrophy, normal diastolic LV dimensions and volume, and mildly depressed LV ejection fraction (LVEF). Morphologic and functional abnormalities on echocardiogram were significantly more severe in subjects with cardiac (<em>n</em>‘= 210), compared with a mixed (<em>n</em> = 298), phenotype: higher median (Q1–Q3) interventricular septal thickness [18 (16–21) vs. 16 (13–20) mm; <em>P</em> = 0.0006]; and more frequent incidence of LVEF &lt;50% (38.1 vs. 17.5%; <em>P</em> = 0.0008). Subjects with cardiac mutations or ATTRwt (or cardiac or mixed phenotype) had a lower survival rate than subjects in other genotype (or the neurologic phenotype) categories (<em>P</em> &lt; 0.0001, for both).</p></section><section id="s3"><h3 class="pmc_sec_title">Conclusion</h3>
<p>ATTR amyloidosis genotypes and phenotypes are highly heterogeneous in continental Western Europe. A geographic map of the different disease profiles and awareness that a subset of subjects have a dominant cardiac phenotype, mimicking hypertrophic cardiomyopathy, at presentation can facilitate the clinical recognition of this underdiagnosed disease.</p></section><section id="s4"><h3 class="pmc_sec_title">Trial registration</h3>
<p>ClinicalTrials.gov: <a href="https://clinicaltrials.gov/ct2/show/NCT00628745" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00628745</a>.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Cardiomyopathy, Registry, ATTR amyloidosis</p></section></section><hr class="headless">
<p>See the editorial comment for this article ‘Transthyretin amyloidosis in Western Europe: a snapshot from the THAOS registry and a call for further perspectives’, by Enrico Ammirati and Omar F. AbouEzzeddine, <a href="https://doi.org/10.1093/eurheartj/ehz205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1093/eurheartj/ehz205</a>.</p>
<section id="sec5"><h2 class="pmc_sec_title">Introduction</h2>
<p>Transthyretin amyloidosis (ATTR amyloidosis) is a group of severe diseases with a broad spectrum of genotypes and heterogeneous phenotypes caused by transthyretin (<em>TTR</em>) gene mutations. ATTR amyloidosis is characterized by the deposition of amyloid fibrils in the heart, peripheral nerves, and other organs.<a href="#ehz173-B1" class="usa-link" aria-describedby="ehz173-B1"><sup>1</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B2" class="usa-link" aria-describedby="ehz173-B2"><sup>2</sup></a> At the level of the heart, insoluble misfolded TTR proteins infiltrate the extracellular matrix, increasing ventricular wall thickness and stiffness of the myocardium, causing an increase in intraventricular pressure with minimal increases in volume.<a href="#ehz173-B2" class="usa-link" aria-describedby="ehz173-B2"><sup>2</sup></a> Patients display a phenotype of hypertrophic cardiomyopathy, associated with heart failure and a poor prognosis.<a href="#ehz173-B2" class="usa-link" aria-describedby="ehz173-B2"><sup>2</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B3" class="usa-link" aria-describedby="ehz173-B3"><sup>3</sup></a> This pattern and symptoms are non-specific and frequently observed in other cardiac diseases, such as hypertensive heart disease or heart failure with preserved ejection fraction.</p>
<p>ATTR amyloidosis has two distinct forms: wild-type ATTR (ATTRwt) amyloidosis (also known as senile systemic amyloidosis) and hereditary ATTR (ATTRm) amyloidosis.<a href="#ehz173-B4" class="usa-link" aria-describedby="ehz173-B4"><sup>4</sup></a> There are more than 100 known pathogenic mutations in the <em>TTR</em> gene<a href="#ehz173-B5" class="usa-link" aria-describedby="ehz173-B5"><sup>5</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B6" class="usa-link" aria-describedby="ehz173-B6"><sup>6</sup></a> including Val30Met, the first described pathogenic mutation,<a href="#ehz173-B7" class="usa-link" aria-describedby="ehz173-B7"><sup>7</sup></a> which is endemic in Portugal, Sweden, Cyprus, and Majorca.<a href="#ehz173-B8" class="usa-link" aria-describedby="ehz173-B8"><sup>8</sup></a></p>
<p>While <em>TTR</em> mutations may be associated with a specific phenotype,<a href="#ehz173-B1" class="usa-link" aria-describedby="ehz173-B1"><sup>1</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B2" class="usa-link" aria-describedby="ehz173-B2"><sup>2</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B9" class="usa-link" aria-describedby="ehz173-B9"><sup>9</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B10" class="usa-link" aria-describedby="ehz173-B10"><sup>10</sup></a> phenotypes may also be influenced by other factors, for example, patient’s country of origin. In Portuguese patients with Val30Met, symptoms emerge in the third decade (defined as early-onset: age &lt;50 years), while in Val30Met patients from other European countries symptoms emerge in the seventh decade (late-onset: age &gt;50 years), and often with a mixed phenotype.<a href="#ehz173-B11" class="usa-link" aria-describedby="ehz173-B11"><sup>11–13</sup></a> Other factors such as age, sex, fibril type, and maternal inheritance may also influence phenotype.<a href="#ehz173-B2" class="usa-link" aria-describedby="ehz173-B2"><sup>2</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B11" class="usa-link" aria-describedby="ehz173-B11"><sup>11</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B14" class="usa-link" aria-describedby="ehz173-B14"><sup>14</sup></a></p>
<p>A patient’s prognosis varies depending on their mutation, age at disease onset, phenotype (cardiac and/or neurologic), and any delay in diagnosis.<a href="#ehz173-B8" class="usa-link" aria-describedby="ehz173-B8"><sup>8</sup></a> Misdiagnosis may, of course, lead to inappropriate cardiac management of the condition.<a href="#ehz173-B2" class="usa-link" aria-describedby="ehz173-B2"><sup>2</sup></a> Recent European Society of Cardiology (ESC) guidelines recommend the consideration of a diagnosis of ATTR-CM in patients with hypertrophic cardiomyopathy.<a href="#ehz173-B16" class="usa-link" aria-describedby="ehz173-B16"><sup>16</sup></a> Therefore, heterogeneity in the frequency of different mutations and phenotypes, age of onset, and prognosis between European countries<a href="#ehz173-B8" class="usa-link" aria-describedby="ehz173-B8"><sup>8</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B10" class="usa-link" aria-describedby="ehz173-B10"><sup>10</sup></a> emphasizes the need to provide more clinical and prognostic data to European cardiologists to increase their awareness and diagnostic skills. With disease modifying treatments being developed,<a href="#ehz173-B15" class="usa-link" aria-describedby="ehz173-B15"><sup>15</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B17" class="usa-link" aria-describedby="ehz173-B17"><sup>17–19</sup></a> it is even more important to improve our understanding of the distribution of patients and of areas of potential underdiagnosis.</p>
<p>Our aims were to investigate genotype distribution, cardiac profile, and the different phenotypes of ATTR amyloidosis observed in Europe using the Transthyretin Amyloidosis Outcomes Survey (THAOS)<a href="#ehz173-B20" class="usa-link" aria-describedby="ehz173-B20"><sup>20</sup></a> and to produce clinical and biological cardiac disease profiles of patients with ATTR amyloidosis.</p></section><section id="sec6"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec7"><h3 class="pmc_sec_title">Source data</h3>
<p>THAOS was established in 2007 and is the largest ongoing, worldwide, longitudinal, observational survey created to study differences in disease presentation, diagnosis, and natural history in a large, geographically dispersed, heterogeneous patient population, and to generate descriptive safety summaries in treated subjects (ClinicalTrials.gov: <a href="https://clinicaltrials.gov/ct2/show/NCT00628745" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00628745</a>).<a href="#ehz173-B20" class="usa-link" aria-describedby="ehz173-B20"><sup>20</sup></a> All study sites received ethical or institutional review board approval prior to subject enrolment, and each subject provided written informed consent. The study followed the International Conference on Harmonisation Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. Data were collected during routine clinical practice at the discretion of the investigator and include cardiac and neurologic findings, renal function assessments, quality of life assessments, hospitalizations, medications, and transplant history.<a href="#ehz173-B20" class="usa-link" aria-describedby="ehz173-B20"><sup>20</sup></a> THAOS is sponsored by Pfizer, which provides financial support for the development and maintenance of the database and compensation to the survey sites for data collection.<a href="#ehz173-B20" class="usa-link" aria-describedby="ehz173-B20"><sup>20</sup></a></p></section><section id="sec8"><h3 class="pmc_sec_title">Study population and assessments</h3>
<p>All symptomatic subjects with confirmed ATTRwt or ATTRm enrolled in the THAOS registry in European countries were included in the analysis. Baseline electrocardiograph data and interventricular septal thickness measurements were collected for the THAOS registry and these data were assessed with respect to subject’s geographical location, genotype, and baseline characteristics (all at time of enrolment in THAOS). Subjects were grouped by both genotype and phenotype. Genotype categories were: ATTRwt; mutations associated with cardiac disease (Val122Ile,<a href="#ehz173-B21" class="usa-link" aria-describedby="ehz173-B21"><sup>21</sup></a> Leu111Met,<a href="#ehz173-B22" class="usa-link" aria-describedby="ehz173-B22"><sup>22</sup></a> Thr60Ala,<a href="#ehz173-B23" class="usa-link" aria-describedby="ehz173-B23"><sup>23</sup></a> or Ile68Leu<a href="#ehz173-B24" class="usa-link" aria-describedby="ehz173-B24"><sup>24</sup></a>); Val30Met mutation with early-onset disease (onset age &lt;50 years); Val30Met mutation with late-onset disease (age ≥50 years); and all other mutations. Phenotype categories, based on clinical presentation at the time of inclusion in THAOS were: mainly neurologic [i.e. TTR-familial amyloid polyneuropathy (TTR-FAP)]; mainly cardiac (i.e. a cardiac phenotype); and mixed (cardiac + neurologic) (see <a href="#sup1" class="usa-link">Supplementary material online</a> for further details).</p>
<p>Simple binary and continuous variables are shown using descriptive statistics. Differences in mean outcomes between genotype and phenotype groups were assessed for statistical significance by: analysis of variance, to calculate <em>P</em>-values by comparing means between groups for continuous variables; the Pearson χ<sup>2</sup> test to calculate <em>P</em>-values for variables with cell counts &gt;5; the Kruskal–Wallis test to calculate <em>P</em>-values by comparing medians between groups for continuous variables; and the Fisher’s exact test to calculate <em>P</em>-values for non-ordinal variables with cell counts ≤5. Follow-up data were obtained from the periodical, scheduled visits (with 6-month intervals). In cases in which no follow-up visits had been made at 1 year from the previous visit, the investigators from the centre enrolling the patient were invited to contact the patient (or relatives) by telephone to retrieve data on vital status. Survival (time to death) and heart transplant-free survival (time to death or heart transplant) were assessed by multivariable prognosis model and shown by the Kaplan–Meier survival curves with Cox proportional hazards model adjusted by age and sex.</p></section></section><section id="sec9"><h2 class="pmc_sec_title">Results</h2>
<section id="sec10"><h3 class="pmc_sec_title">Subject demographics and genotype</h3>
<p>As of January 2016, 1417 symptomatic subjects in nine European countries were enrolled in THAOS, all of these in continental Western Europe. Of these, there were 1411 symptomatic subjects across the nine countries with subject data (<em>Table <a href="#ehz173-T1" class="usa-link">1</a></em> and <em>Figure <a href="#ehz173-F1" class="usa-link">1</a></em> show the distribution across countries). Of the symptomatic subjects, 125 had ATTRwt [115 males (92.0%) and 10 females (8.0%)], and 1286 had ATTRm [677 males (52.6%) and 609 females (47.4%)]. There were 54 different <em>TTR</em> mutations represented in the population; 16 of these were shared by ≥5 subjects (<em>Table <a href="#ehz173-T1" class="usa-link">1</a></em>).</p>
<section class="tw xbox font-sm" id="ehz173-T1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Phenotype and genotype by country<a href="#tblfn1" class="usa-link"><sup>a</sup></a></p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col valign="top" align="left" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
</colgroup>
<thead><tr>
<th rowspan="1" colspan="1"></th>
<th rowspan="1" colspan="1">Germany (<em>N</em> = 125)</th>
<th rowspan="1" colspan="1">Denmark (<em>N</em> = 23)</th>
<th rowspan="1" colspan="1">Spain (<em>N</em> = 76)</th>
<th rowspan="1" colspan="1">France (<em>N</em> = 94)</th>
<th rowspan="1" colspan="1">Italy (<em>N</em> = 161)</th>
<th rowspan="1" colspan="1">Portugal (<em>N</em> = 786)</th>
<th rowspan="1" colspan="1">Sweden (<em>N</em> = 142)</th>
<th rowspan="1" colspan="1">Total<a href="#tblfn1" class="usa-link"><sup>a</sup></a> (<em>N</em> = 1411)</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Phenotype, <em>n</em> (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Cardiac</td>
<td rowspan="1" colspan="1">64 (51.2)</td>
<td rowspan="1" colspan="1">18 (78.3)</td>
<td rowspan="1" colspan="1">13 (17.1)</td>
<td rowspan="1" colspan="1">13 (13.8)</td>
<td rowspan="1" colspan="1">58 (36.0)</td>
<td rowspan="1" colspan="1">25 (3.2)</td>
<td rowspan="1" colspan="1">19 (13.4)</td>
<td rowspan="1" colspan="1">210 (14.9)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Cardiac + neurologic</td>
<td rowspan="1" colspan="1">22 (17.6)</td>
<td rowspan="1" colspan="1">2 (8.7)</td>
<td rowspan="1" colspan="1">20 (26.3)</td>
<td rowspan="1" colspan="1">39 (41.5)</td>
<td rowspan="1" colspan="1">45 (28.0)</td>
<td rowspan="1" colspan="1">135 (17.2)</td>
<td rowspan="1" colspan="1">32 (22.5)</td>
<td rowspan="1" colspan="1">298 (21.1)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Neurologic</td>
<td rowspan="1" colspan="1">39 (31.2)</td>
<td rowspan="1" colspan="1">3 (13.0)</td>
<td rowspan="1" colspan="1">43 (56.6)</td>
<td rowspan="1" colspan="1">42 (44.7)</td>
<td rowspan="1" colspan="1">58 (36.0)</td>
<td rowspan="1" colspan="1">626 (79.6)</td>
<td rowspan="1" colspan="1">91 (64.1)</td>
<td rowspan="1" colspan="1">903 (64.0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Genotype, <em>n</em>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Val30Met</td>
<td rowspan="1" colspan="1">24</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">56</td>
<td rowspan="1" colspan="1">42</td>
<td rowspan="1" colspan="1">7</td>
<td rowspan="1" colspan="1">779</td>
<td rowspan="1" colspan="1">128</td>
<td rowspan="1" colspan="1">1038</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Wild type</td>
<td rowspan="1" colspan="1">52</td>
<td rowspan="1" colspan="1">11</td>
<td rowspan="1" colspan="1">3</td>
<td rowspan="1" colspan="1">3</td>
<td rowspan="1" colspan="1">55</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">125</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Ile68Leu</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">26</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">28</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Glu89Gln</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">24</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">25</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Phe64Leu</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">19</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">19</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Val122Ile</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">3</td>
<td rowspan="1" colspan="1">12</td>
<td rowspan="1" colspan="1">2</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">18</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Ser77Tyr</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">2</td>
<td rowspan="1" colspan="1">15</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">17</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Gly47Ala</td>
<td rowspan="1" colspan="1">11</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">4</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">15</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Val20Ile</td>
<td rowspan="1" colspan="1">12</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">12</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Ile107Val</td>
<td rowspan="1" colspan="1">6</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">5</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">11</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Leu111Met</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">11</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">11</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Thr49Ala</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">9</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Val28Met</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">2</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">6</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Glu89Lys</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">5</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> His88Arg</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">6</td>
<td rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> DelVal122</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">4</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">5</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Thr59Lys</td>
<td rowspan="1" colspan="1">2</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">3</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">5</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Thr60Ala</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> All other genotypes<a href="#tblfn2" class="usa-link"><sup>b</sup></a>
</td>
<td rowspan="1" colspan="1">16</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">2</td>
<td rowspan="1" colspan="1">13</td>
<td rowspan="1" colspan="1">10</td>
<td rowspan="1" colspan="1">1</td>
<td rowspan="1" colspan="1">5</td>
<td rowspan="1" colspan="1">50</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Genotype category, <em>n</em> (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Wild type</td>
<td rowspan="1" colspan="1">52 (41.6)</td>
<td rowspan="1" colspan="1">11 (47.8)</td>
<td rowspan="1" colspan="1">3 (3.9)</td>
<td rowspan="1" colspan="1">3 (3.2)</td>
<td rowspan="1" colspan="1">55 (34.2)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1 (0.7)</td>
<td rowspan="1" colspan="1">125 (8.9)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Cardiac mutations<a href="#tblfn3" class="usa-link"><sup>c</sup></a>
</td>
<td rowspan="1" colspan="1">1 (0.80)</td>
<td rowspan="1" colspan="1">11 (47.8)</td>
<td rowspan="1" colspan="1">3 (3.9)</td>
<td rowspan="1" colspan="1">13 (13.8)</td>
<td rowspan="1" colspan="1">28 (17.4)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">2 (1.4)</td>
<td rowspan="1" colspan="1">58 (4.1)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Val30Met early-onset</td>
<td rowspan="1" colspan="1">13 (10.4)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">31 (40.8)</td>
<td rowspan="1" colspan="1">27 (28.7)</td>
<td rowspan="1" colspan="1">3 (1.9)</td>
<td rowspan="1" colspan="1">646 (82.2)</td>
<td rowspan="1" colspan="1">39 (27.5)</td>
<td rowspan="1" colspan="1">761 (53.9)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Val30Met late-onset</td>
<td rowspan="1" colspan="1">11 (8.8)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">25 (32.9)</td>
<td rowspan="1" colspan="1">15 (16.0)</td>
<td rowspan="1" colspan="1">4 (2.5)</td>
<td rowspan="1" colspan="1">133 (16.9)</td>
<td rowspan="1" colspan="1">89 (62.7)</td>
<td rowspan="1" colspan="1">277 (19.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Other non-cardiac</td>
<td rowspan="1" colspan="1">48 (38.4)</td>
<td rowspan="1" colspan="1">1 (4.4)</td>
<td rowspan="1" colspan="1">14 (18.4)</td>
<td rowspan="1" colspan="1">36 (38.3)</td>
<td rowspan="1" colspan="1">71 (44.1)</td>
<td rowspan="1" colspan="1">7 (0.9)</td>
<td rowspan="1" colspan="1">11 (7.8)</td>
<td rowspan="1" colspan="1">190 (13.5)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ehz173-T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tblfn1">
<sup>a</sup><p class="display-inline">Not shown separately in table, but included in ‘Total’ column are: Belgium, three subjects with cardiac + neurologic phenotype including one subject each with Val30Met (early-onset), Glu54Leu, and Glu74Leu; Cyprus, one subject with neurologic phenotype, and Val30Met (early-onset). Thr60Ala is shown separately as it is a designated ‘cardiac mutation’.</p>
</div>
<div class="fn" id="tblfn2">
<sup>b</sup><p class="display-inline">All other genotypes with ≤3 subjects in total. These are genotypes Arg34Thr and Ser77Phe (three subjects each); Ala45Ser, Cys10Arg, Glu54Lys, Ile84Thr, Ser50Arg, Thr49Ile, Tyr116Ser, and Val71Ala (two subjects each); and Ala19Asp, Ala36Pro, Ala45Asp, Ala81Thr, Ala91Ser, Ala97Ser, Arg21Gln, Asp18Glu, Glu42Gly, Glu54Gln, Glu54Gly, Glu54Leu, Glu62Lys, Glu92Lys, Gly47Arg, Gly47Glu, Gly53Ala, Gly6Ser/Thr49Ile, Ile107Met, Phe84Leu, Ser23Asn, Ser52Pro, Thr40Asn, Thr75Ile, Val30Leu, and Val93Leu (one subject each).</p>
</div>
<div class="fn" id="tblfn3">
<sup>c</sup><p class="display-inline">Cardiac mutations are Val122Ile, Leu111Met, Thr60Ala, and Ile68Leu.</p>
</div>
</div></section><figure class="fig xbox font-sm" id="ehz173-F1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8825236_ehz173f1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a2b/8825236/03d1ef8728f5/ehz173f1.jpg" loading="lazy" height="501" width="738" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/ehz173-F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Subject phenotypes and most common genotype in subjects enrolled in THAOS in continental Western Europe. Data are from all European countries included in THAOS. Shown are: the total number of subjects from each country in THAOS, the proportions of each phenotype, and the most common mutation in each country (with its percentage of all subjects in that country). Not shown are: Belgium, three subjects with cardiac + neurologic phenotype (genotypes: Val30Met, Glu54Leu, and Glu74Leu); and Cyprus, one subject with neurologic phenotype (genotype: Val30Met). Note that the most common form of ATTR amyloidosis in Germany and Italy was ATTRwt (41.6% and 34.2% of all subjects, respectively).</p></figcaption></figure><p>In subjects with ATTRm in European countries in the THAOS registry, Val30Met was the most frequent mutation (1038 subjects, 73.6%), with most of these subjects being from Portugal, followed by Ile68Leu (28 subjects, 2.0%), with most subjects from Italy (<em>Table <a href="#ehz173-T1" class="usa-link">1</a></em>). Types of mutations present differed highly between: Portugal and Sweden, in which there were endemic aggregations of Val30Met [779 (99.1%) and 128 (90.1%) subjects, respectively]; and the other European countries, which had a greater distribution of genotypes (<em>Table <a href="#ehz173-T1" class="usa-link">1</a></em>). However, the majority of Val30Met subjects in Portugal were early-onset Val30Met, while the majority in Sweden were late-onset Val30Met (<a href="#sup1" class="usa-link">Supplementary material online</a>, <em><a href="#sup1" class="usa-link">Figure S1</a></em>). ATTRwt was observed in all countries except Portugal, Belgium, and Cyprus. There were also differences among countries in diagnostic pathways and treatment practices, and in subjects’ cardiac morphology, with Sweden having a higher proportion of subjects with a ratio of interventricular septal thickness to posterior wall thickness &gt;1.3 (<a href="#sup1" class="usa-link">Supplementary material online</a>, <em><a href="#sup1" class="usa-link">Tables S1 and S2</a></em>).</p></section><section id="sec11"><h3 class="pmc_sec_title">Subject phenotypes by genotype category</h3>
<p>Subject age, age at symptom onset, and sex varied significantly by genotype category (<a href="#sup1" class="usa-link">Supplementary material online</a>, <em><a href="#sup1" class="usa-link">Table S3</a></em>). Clinical phenotype at presentation in the overall registry was ‘cardiac’ in 210 subjects (14.9%), ‘cardiac + neurologic’ (mixed) in 298 subjects (21.1%), and ‘neurologic’ in 903 subjects (64.0%) (<em>Table <a href="#ehz173-T2" class="usa-link">2</a></em>). The proportion of the neurologic phenotype in the overall cohort was driven by Portugal, Sweden, and Spain, where it was present in 79.6, 64.1, and 56.6% of subjects, respectively, mostly due to Val30Met. In other countries, such as Germany, Denmark, France, and Italy, most subjects had a cardiac or cardiac + neurologic phenotype (<em>Table <a href="#ehz173-T1" class="usa-link">1</a></em>).</p>
<section class="tw xbox font-sm" id="ehz173-T2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Selected electrocardiogram and echocardiogram characteristics by genotype category</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col valign="top" align="left" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
</colgroup>
<thead><tr>
<th rowspan="1" colspan="1">Genotype</th>
<th rowspan="1" colspan="1">Total (<em>N</em> = 1411)</th>
<th rowspan="1" colspan="1">ATTRwt (<em>N</em> = 125)</th>
<th rowspan="1" colspan="1">Four main cardiac mutations (<em>N</em> = 58)</th>
<th rowspan="1" colspan="1">Val30Met early-onset (<em>N</em> = 761)</th>
<th rowspan="1" colspan="1">Val30Met late-onset (<em>N</em> = 277)</th>
<th rowspan="1" colspan="1">Other mutations (<em>N</em> = 190)</th>
<th rowspan="1" colspan="1">
<em>P</em>-value</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Phenotype, <em>n</em> (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Cardiac</td>
<td rowspan="1" colspan="1">210 (14.9)</td>
<td rowspan="1" colspan="1">99 (79.2)</td>
<td rowspan="1" colspan="1">28 (48.3)</td>
<td rowspan="1" colspan="1">25 (3.3)</td>
<td rowspan="1" colspan="1">25 (9.0)</td>
<td rowspan="1" colspan="1">33 (17.4)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Cardiac + neurologic</td>
<td rowspan="1" colspan="1">298 (21.1)</td>
<td rowspan="1" colspan="1">23 (18.4)</td>
<td rowspan="1" colspan="1">17 (29.3)</td>
<td rowspan="1" colspan="1">126 (16.6)</td>
<td rowspan="1" colspan="1">74 (26.7)</td>
<td rowspan="1" colspan="1">58 (30.5)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Neurologic</td>
<td rowspan="1" colspan="1">903 (64.0)</td>
<td rowspan="1" colspan="1">3 (2.4)</td>
<td rowspan="1" colspan="1">13 (22.4)</td>
<td rowspan="1" colspan="1">610 (80.2)</td>
<td rowspan="1" colspan="1">178 (64.3)</td>
<td rowspan="1" colspan="1">99 (52.1)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">ECG abnormal, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">514 (53.8)</td>
<td rowspan="1" colspan="1">104 (96.3)</td>
<td rowspan="1" colspan="1">39 (81.3)</td>
<td rowspan="1" colspan="1">188 (36.2)</td>
<td rowspan="1" colspan="1">102 (62.6)</td>
<td rowspan="1" colspan="1">81 (69.2)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Pathologic Q-waves observed, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">113 (26.8)</td>
<td rowspan="1" colspan="1">48 (50.0)</td>
<td rowspan="1" colspan="1">17 (47.2)</td>
<td rowspan="1" colspan="1">2 (1.4)</td>
<td rowspan="1" colspan="1">18 (25.4)</td>
<td rowspan="1" colspan="1">28 (35.9)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Low voltage, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">98 (12.8)</td>
<td rowspan="1" colspan="1">23 (24.0)</td>
<td rowspan="1" colspan="1">15 (40.5)</td>
<td rowspan="1" colspan="1">32 (7.5)</td>
<td rowspan="1" colspan="1">4 (3.7)</td>
<td rowspan="1" colspan="1">24 (24.5)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Interval PR, median (Q1–Q3)</td>
<td rowspan="1" colspan="1">168.0 (146.0–194.0)</td>
<td rowspan="1" colspan="1">185.0 (130.0–208.0)</td>
<td rowspan="1" colspan="1">186.0 (126.0–226.0)</td>
<td rowspan="1" colspan="1">168.0 (148.0–191.5)</td>
<td rowspan="1" colspan="1">172.0 (149.0–200.0)</td>
<td rowspan="1" colspan="1">160.0 (140.0–183.0)</td>
<td rowspan="1" colspan="1">0.2434</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Interval QRS, median (Q1–Q3)</td>
<td rowspan="1" colspan="1">98.0 (89.0–112.0)</td>
<td rowspan="1" colspan="1">122.0 (104.0–153.0)</td>
<td rowspan="1" colspan="1">112.0 (90.0–124.0)</td>
<td rowspan="1" colspan="1">94.0 (88.0–102.0)</td>
<td rowspan="1" colspan="1">104.0 (94.0–118.0)</td>
<td rowspan="1" colspan="1">98.0 (86.0–117.0)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">LBBB, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">53 (17.6)</td>
<td rowspan="1" colspan="1">24 (31.2)</td>
<td rowspan="1" colspan="1">10 (37.0)</td>
<td rowspan="1" colspan="1">5 (5.2)</td>
<td rowspan="1" colspan="1">8 (17.0)</td>
<td rowspan="1" colspan="1">6 (11.1)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">RBBB, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">45 (14.7)</td>
<td rowspan="1" colspan="1">17 (21.8)</td>
<td rowspan="1" colspan="1">5 (17.9)</td>
<td rowspan="1" colspan="1">3 (3.1)</td>
<td rowspan="1" colspan="1">7 (14.6)</td>
<td rowspan="1" colspan="1">13 (23.6)</td>
<td rowspan="1" colspan="1">0.0019</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Diastolic interventricular septum thickness, median (Q1–Q3)</td>
<td rowspan="1" colspan="1">15 (11–19)</td>
<td rowspan="1" colspan="1">18 (16–21)</td>
<td rowspan="1" colspan="1">17 (13–20)</td>
<td rowspan="1" colspan="1">10 (9–12)</td>
<td rowspan="1" colspan="1">15.5 (12–18)</td>
<td rowspan="1" colspan="1">16 (12–20)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">LV diastolic diameter, median (Q1–Q3)</td>
<td rowspan="1" colspan="1">45 (42–50)</td>
<td rowspan="1" colspan="1">46 (42–50)</td>
<td rowspan="1" colspan="1">46 (43–49)</td>
<td rowspan="1" colspan="1">45 (42–49)</td>
<td rowspan="1" colspan="1">47 (44–51)</td>
<td rowspan="1" colspan="1">45 (40–49)</td>
<td rowspan="1" colspan="1">0.0521</td>
</tr>
<tr>
<td rowspan="1" colspan="1">LV ejection fraction (%), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">65.1 (54.3–71.1)</td>
<td rowspan="1" colspan="1">55.5 (46.0–66.3)</td>
<td rowspan="1" colspan="1">59.2 (51.1–69.0)</td>
<td rowspan="1" colspan="1">69.5 (63.3–74.0)</td>
<td rowspan="1" colspan="1">70.2 (61.8–74.9)</td>
<td rowspan="1" colspan="1">62.5 (50.2–68.7)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">E-wave deceleration time (ms), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">183.0 (141.0–221.0)</td>
<td rowspan="1" colspan="1">180.0 (144.0–205.0)</td>
<td rowspan="1" colspan="1">160.0 (140.0–215.0)</td>
<td rowspan="1" colspan="1">178.0 (129.0–204.0)</td>
<td rowspan="1" colspan="1">228.0 (180.0–261.0)</td>
<td rowspan="1" colspan="1">182.0 (141.0–218.0)</td>
<td rowspan="1" colspan="1">0.0008</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Stroke volume (mL), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">68.0 (54.0–83.0)</td>
<td rowspan="1" colspan="1">54.0 (39.0–68.0)</td>
<td rowspan="1" colspan="1">50.0 (45.0–56.0)</td>
<td rowspan="1" colspan="1">70.0 (56.5–82.0)</td>
<td rowspan="1" colspan="1">82.0 (69.0–94.0)</td>
<td rowspan="1" colspan="1">52.5 (42.0–64.5)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">RV free wall thickness, median (Q1–Q3)</td>
<td rowspan="1" colspan="1">7.0 (5.0–8.0)</td>
<td rowspan="1" colspan="1">9.0 (7.0–11.0)</td>
<td rowspan="1" colspan="1">7.0 (7.0–9.0)</td>
<td rowspan="1" colspan="1">6.0 (5.0–7.0)</td>
<td rowspan="1" colspan="1">7.0 (5.0–9.0)</td>
<td rowspan="1" colspan="1">6.0 (5.0–8.0)</td>
<td rowspan="1" colspan="1">0.0008</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Aortic thickening, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">50 (24.3)</td>
<td rowspan="1" colspan="1">16 (26.7)</td>
<td rowspan="1" colspan="1">5 (20.8)</td>
<td rowspan="1" colspan="1">10 (21.3)</td>
<td rowspan="1" colspan="1">6 (27.3)</td>
<td rowspan="1" colspan="1">13 (24.5)</td>
<td rowspan="1" colspan="1">0.9537</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Mitral thickening, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">58 (27.9)</td>
<td rowspan="1" colspan="1">23 (37.7)</td>
<td rowspan="1" colspan="1">6 (24.0)</td>
<td rowspan="1" colspan="1">5 (10.6)</td>
<td rowspan="1" colspan="1">2 (9.1)</td>
<td rowspan="1" colspan="1">22 (41.5)</td>
<td rowspan="1" colspan="1">0.0009</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Tricuspid thickening, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">19 (9.5)</td>
<td rowspan="1" colspan="1">12 (20.0)</td>
<td rowspan="1" colspan="1">2 (8.7)</td>
<td rowspan="1" colspan="1">0 (0.0)</td>
<td rowspan="1" colspan="1">1 (4.5)</td>
<td rowspan="1" colspan="1">4 (8.2)</td>
<td rowspan="1" colspan="1">0.0100</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Sparkling, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">192 (50.7)</td>
<td rowspan="1" colspan="1">63 (74.1)</td>
<td rowspan="1" colspan="1">11 (39.3)</td>
<td rowspan="1" colspan="1">42 (42.9)</td>
<td rowspan="1" colspan="1">33 (44.6)</td>
<td rowspan="1" colspan="1">43 (45.7)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ehz173-T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tblfn4"><p>Percentages shown are the proportion of subjects with each measure out of the total number of subjects for which data on that measure was available. Analysis of variance was performed to calculate <em>P</em>-values by comparing means between groups for continuous variables. The Pearson χ<sup>2</sup> test was performed to calculate <em>P</em>-values for variables with cell counts &gt;5. The Kruskal–Wallis test was performed to calculate <em>P</em>-values by comparing medians between groups for continuous variables. The Fisher’s exact test was performed to calculate <em>P</em>-values for non-ordinal variables with cell counts ≤5.</p></div>
<div class="fn" id="tblfn5"><p>ATTRwt, wild-type ATTR amyloidosis; LBBB, left bundle branch block; LV, left ventricular; Q1, lower quartile; Q3, upper quartile; RBBB, right bundle branch block.</p></div>
</div></section></section><section id="sec12"><h3 class="pmc_sec_title">Clinical assessments by genotype category</h3>
<p>ATTRwt subjects, and subjects with cardiac mutations, were more likely to: be male; have a greater age at symptom onset; have a history of palpitations or heart failure; be receiving treatment for heart disease; have higher levels of brain natriuretic peptide (BNP) and N-terminal pro-BNP (NTproBNP), troponin I + troponin T, and creatinine; and have a lower estimated glomerular filtration rate (<a href="#sup1" class="usa-link">Supplementary material online</a>, <em><a href="#sup1" class="usa-link">Table S3</a></em>). These subjects were also more likely to have abnormal electrocardiogram (ECG) results and showed normal diastolic left ventricular (LV) volume, symmetric LV hypertrophy, and mildly depressed LV ejection fraction (LVEF; <em>Table <a href="#ehz173-T2" class="usa-link">2</a></em>). All genotype categories had increased diastolic interventricular septum thickness (median ≥15 mm), with the exception of early-onset Val30Met, which had a median of 10 mm (<em>Table <a href="#ehz173-T2" class="usa-link">2</a></em>).</p>
<p>In the cardiac mutations category, subject demographics were similar between subjects with Val122Ile, Thr60Ala, and Ile68Leu mutations, while subjects with Leu111Met were significantly younger, and less likely to be male. Subjects with the Leu111Met mutation were 63.6% male and had a mean [standard deviation (SD)] age at enrolment and mean (SD) age at symptom onset of 47.6 (7.4) and 38.9 (8.9) years, compared with 86.9% male and 72.2 (9.8) and 65.1 (12.1) years in all subjects with cardiac mutations or ATTRwt.</p></section><section id="sec13"><h3 class="pmc_sec_title">Clinical assessments by phenotype category</h3>
<p>Morphologic and functional abnormalities on echocardiogram were significantly more severe among subjects with the cardiac phenotype compared with the cardiac + neurologic phenotype (<em>Table <a href="#ehz173-T3" class="usa-link">3</a></em>). The cardiac phenotype had: higher median (Q1–Q3) diastolic interventricular septum thickness [18 (16–21) vs. 16 (13–20) mm; <em>P</em> = 0.0006]; more frequent incidence of LVEF &lt;50% (38.1 vs. 17.5%; <em>P</em> = 0.0008); and more frequent incidence of higher echo-Doppler restrictive filling pattern (&gt;2 in 48.0 vs. 18.5%; <em>P</em> = 0.0240), compared with the cardiac + neurologic phenotype.</p>
<section class="tw xbox font-sm" id="ehz173-T3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Comparisons of clinical and electrocardiogram and echocardiogram characteristics in symptomatic subjects with cardiac or cardiac + neurologic phenotype</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col valign="top" align="left" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
<col valign="top" align="char" char="" span="1">
</colgroup>
<thead><tr>
<th rowspan="1" colspan="1"></th>
<th rowspan="1" colspan="1">
<em>N</em> (total)</th>
<th rowspan="1" colspan="1">Total (<em>N</em> = 508)</th>
<th rowspan="1" colspan="1">Cardiac (<em>N</em> = 210)</th>
<th rowspan="1" colspan="1">Cardiac + neurologic (<em>N</em> = 298)</th>
<th rowspan="1" colspan="1">
<em>P</em>-value</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Age at onset (years), mean (SD)</td>
<td rowspan="1" colspan="1">508</td>
<td rowspan="1" colspan="1">53.1 (16.9)</td>
<td rowspan="1" colspan="1">60.8 (14.5)</td>
<td rowspan="1" colspan="1">47.6 (16.3)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age at inclusion (years), mean (SD)</td>
<td rowspan="1" colspan="1">508</td>
<td rowspan="1" colspan="1">61.3 (15.5)</td>
<td rowspan="1" colspan="1">67.3 (13.5)</td>
<td rowspan="1" colspan="1">57.0 (15.5)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Sex, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">508</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Male</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">335 (65.9)</td>
<td rowspan="1" colspan="1">164 (78.1)</td>
<td rowspan="1" colspan="1">171 (57.4)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Female</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">173 (34.1)</td>
<td rowspan="1" colspan="1">46 (21.9)</td>
<td rowspan="1" colspan="1">127 (42.6)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">NYHA</td>
<td rowspan="1" colspan="1">501</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> No HF/I</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">265 (52.9)</td>
<td rowspan="1" colspan="1">68 (32.5)</td>
<td rowspan="1" colspan="1">197 (67.5)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> II–IV</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">236 (47.1)</td>
<td rowspan="1" colspan="1">141 (67.5)</td>
<td rowspan="1" colspan="1">95 (32.5)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Diastolic interventricular septum thickness (mm), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">270</td>
<td rowspan="1" colspan="1">17.0 (14.0–20.0)</td>
<td rowspan="1" colspan="1">18.0 (16.0–21.0)</td>
<td rowspan="1" colspan="1">16.0 (13.0–20.0)</td>
<td rowspan="1" colspan="1">0.0006</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Diastolic LV posterior wall thickness (mm), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">248</td>
<td rowspan="1" colspan="1">15.0 (12.0–18.0)</td>
<td rowspan="1" colspan="1">16.0 (13.0–18.0)</td>
<td rowspan="1" colspan="1">13.0 (10.0–17.0)</td>
<td rowspan="1" colspan="1">0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Left atrial diameter (mm), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">221</td>
<td rowspan="1" colspan="1">43.0 (39.0–48.0)</td>
<td rowspan="1" colspan="1">46.0 (42.0–50.0)</td>
<td rowspan="1" colspan="1">41.0 (36.0–46.0)</td>
<td rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td rowspan="1" colspan="1">LV ejection fraction (%), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">216</td>
<td rowspan="1" colspan="1">60.9 (48.6–69.8)</td>
<td rowspan="1" colspan="1">55.5 (46.4–68.0)</td>
<td rowspan="1" colspan="1">65.3 (57.4–70.8)</td>
<td rowspan="1" colspan="1">0.0002</td>
</tr>
<tr>
<td rowspan="1" colspan="1">LV ejection fraction &lt;40%, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">216</td>
<td rowspan="1" colspan="1">20 (9.3)</td>
<td rowspan="1" colspan="1">14 (12.4)</td>
<td rowspan="1" colspan="1">6 (5.8)</td>
<td rowspan="1" colspan="1">0.0964</td>
</tr>
<tr>
<td rowspan="1" colspan="1">LV ejection fraction &lt;50%, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">216</td>
<td rowspan="1" colspan="1">61 (28.2)</td>
<td rowspan="1" colspan="1">43 (38.1)</td>
<td rowspan="1" colspan="1">18 (17.5)</td>
<td rowspan="1" colspan="1">0.0008</td>
</tr>
<tr>
<td rowspan="1" colspan="1">LV end-diastolic diameter (mm), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">237</td>
<td rowspan="1" colspan="1">45.0 (42.0–49.0)</td>
<td rowspan="1" colspan="1">45.0 (42.0–50.0)</td>
<td rowspan="1" colspan="1">45.0 (41.0–48.0)</td>
<td rowspan="1" colspan="1">0.5533</td>
</tr>
<tr>
<td rowspan="1" colspan="1">E-wave deceleration time (ms), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">118</td>
<td rowspan="1" colspan="1">179.0 (144.0–221.0)</td>
<td rowspan="1" colspan="1">175.5 (142.0–200.0)</td>
<td rowspan="1" colspan="1">183.5 (144.0–226.0)</td>
<td rowspan="1" colspan="1">0.3134</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Stroke volume (mL), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">71</td>
<td rowspan="1" colspan="1">60 (49–75)</td>
<td rowspan="1" colspan="1">55 (48–69)</td>
<td rowspan="1" colspan="1">62 (50–76)</td>
<td rowspan="1" colspan="1">0.2637</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Restrictive filling pattern, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">79</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">0.0240</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> &lt;1</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">20 (25.3)</td>
<td rowspan="1" colspan="1">5 (20.0)</td>
<td rowspan="1" colspan="1">15 (27.8)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> 1–2</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">37 (46.8)</td>
<td rowspan="1" colspan="1">8 (32.0)</td>
<td rowspan="1" colspan="1">29 (53.7)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1"> &gt;2</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">22 (27.8)</td>
<td rowspan="1" colspan="1">12 (48.0)</td>
<td rowspan="1" colspan="1">10 (18.5)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">LV mass among men (g/m<sup>2</sup>), median (Q1–Q3)</td>
<td rowspan="1" colspan="1">172</td>
<td rowspan="1" colspan="1">336.4 (267.0–412.5)</td>
<td rowspan="1" colspan="1">350.7 (295.0–427.0)</td>
<td rowspan="1" colspan="1">298.4 (212.0–389.9)</td>
<td rowspan="1" colspan="1">0.0069</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Mitral thickening, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">140</td>
<td rowspan="1" colspan="1">44 (31.4)</td>
<td rowspan="1" colspan="1">26 (32.9)</td>
<td rowspan="1" colspan="1">18 (29.5)</td>
<td rowspan="1" colspan="1">0.6671</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Tricuspid thickening, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">136</td>
<td rowspan="1" colspan="1">18 (13.2)</td>
<td rowspan="1" colspan="1">11 (14.1)</td>
<td rowspan="1" colspan="1">7 (12.1)</td>
<td rowspan="1" colspan="1">0.7293</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ehz173-T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tblfn6"><p>Percentages shown are the proportion of subjects with each measure out of the total number of subjects for which data on that measure was available. The Kruskal–Wallis test was performed to calculate <em>P</em>-values by comparing medians between groups for continuous variables. The Pearson χ<sup>2</sup> test was performed to calculate <em>P</em>-values for variables with cell counts &gt;5.</p></div>
<div class="fn" id="tblfn7"><p>HF, heart failure; LV, left ventricular; NYHA, New York Heart Association (classification); Q1, lower quartile; Q3, upper quartile; SD, standard deviation.</p></div>
</div></section></section><section id="sec14"><h3 class="pmc_sec_title">Survival by genotype and phenotype category</h3>
<p>Survival (time to death) and heart transplant-free survival (time to death or heart transplant) was assessed for all 1375 subjects with follow-up data. Subjects with cardiac mutations or ATTRwt genotype had a lower survival rate than subjects in the other genotype categories (χ<sup>2</sup> log rank: <em>P</em> &lt; 0.0001) (<em>Figure <a href="#ehz173-F2" class="usa-link">2</a></em> and <a href="#sup1" class="usa-link">Supplementary material online</a>, <em><a href="#sup1" class="usa-link">Figure S2</a></em>). Subjects with cardiac or cardiac + neurologic phenotype had a lower survival rate than subjects with neurologic phenotype (χ<sup>2</sup> log rank: <em>P</em> &lt; 0.0001) (<em>Figure <a href="#ehz173-F3" class="usa-link">3</a></em> and <a href="#sup1" class="usa-link">Supplementary material online</a>, <em><a href="#sup1" class="usa-link">Figure S3</a></em>).
</p>
<figure class="fig xbox font-sm" id="ehz173-F2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8825236_ehz173f2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a2b/8825236/a9d8c7441386/ehz173f2.jpg" loading="lazy" height="446" width="755" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/ehz173-F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>A Kaplan–Meier survival curve by genotype for subject death. The 95% Hall–Wellner bands and Cox proportional hazards model are adjusted by age and sex (χ<sup>2</sup> log rank: <em>P</em> &lt; 0.0001). Survival curves are from enrolment in THAOS.</p></figcaption></figure><figure class="fig xbox font-sm" id="ehz173-F3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8825236_ehz173f3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a2b/8825236/e3964c83d269/ehz173f3.jpg" loading="lazy" height="425" width="755" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/ehz173-F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>A Kaplan–Meier survival curve by phenotype for subject death. The 95% Hall–Wellner bands and Cox proportional hazards model are adjusted by age and sex (χ<sup>2</sup> log rank: <em>P</em> &lt; 0.0001). Survival curves are from enrolment in THAOS.</p></figcaption></figure></section></section><section id="sec15"><h2 class="pmc_sec_title">Discussion</h2>
<p>This study provides, for the first time, a detailed map of the genotypic and phenotypic distribution of ATTR amyloidosis in Europe. The THAOS registry offers a unique opportunity to assess the phenotype, genotype, and prognosis spectrum, and represents a model for the study of rare disease. This analysis of THAOS registry subjects in Europe demonstrates that both genotype and phenotype are highly heterogeneous among patients with ATTR amyloidosis and that cardiac symptoms, or phenotype, are common in these patients; suggesting that European cardiologists might often be the first in line to diagnose patients with ATTR amyloidosis hidden in the large community of patients with cardiac symptoms/disease and, importantly, that the prognosis of ATTR amyloidosis is driven by the degree of cardiac involvement.</p>
<section id="sec16"><h3 class="pmc_sec_title">Heterogeneity of ATTR amyloidosis genotype in continental Western Europe</h3>
<p>The THAOS registry has confirmed the heterogeneity of distribution of the mutations across continental Western European countries, with some mutations specific to certain countries. For instance, cardiac mutations Leu111Met, Ile68Leu, and Val122Ile were predominantly observed in Denmark, Italy, and France, respectively. Leu111Met has been traced to three unrelated Danish families.<a href="#ehz173-B22" class="usa-link" aria-describedby="ehz173-B22"><sup>22</sup></a> Val122Ile is observed in patients from West Africa, or of West African descent, with 3.4% of African Americans aged &lt;65 years carrying at least one copy of the mutation.<a href="#ehz173-B21" class="usa-link" aria-describedby="ehz173-B21"><sup>21</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B25" class="usa-link" aria-describedby="ehz173-B25"><sup>25</sup></a> Thr60Ala was observed in only one subject in THAOS in continental Western Europe (in Sweden, with no known ancestry from Ireland or the UK, where it is the most common mutation<a href="#ehz173-B23" class="usa-link" aria-describedby="ehz173-B23"><sup>23</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B26" class="usa-link" aria-describedby="ehz173-B26"><sup>26</sup></a>). The UK does not participate in THAOS, but in one observational study, Thr60Ala was the single most common mutation (17 of 37 patients with ATTRm), followed by Val30Met (five patients).<a href="#ehz173-B9" class="usa-link" aria-describedby="ehz173-B9"><sup>9</sup></a> Val30Met is endemic in Portugal (predominantly early-onset) and Sweden (predominantly late-onset), and also observed in Spain and France. This analysis of THAOS shows that distribution of <em>TTR</em> mutations across continental Western Europe varies significantly among different countries, or in some ethnic groups, due to the founder effect. Therefore, the main mutations come from endemic areas (e.g. early-onset Val30Met from Portugal and Val122Ile from West Africa) from which subjects have migrated across Europe over time. In contrast to cardiac mutations, ATTRwt was observed in all continental Western European countries. This suggests that ATTRwt is linked to the ageing process, rather than to other genetic factors, and that it can occur in any elderly European.<a href="#ehz173-B27" class="usa-link" aria-describedby="ehz173-B27"><sup>27</sup></a></p></section><section id="sec17"><h3 class="pmc_sec_title">Time of onset and sex of subjects with cardiac mutations in continental Western Europe</h3>
<p>Patients with cardiac phenotype had a range of ages at disease onset. Val122Ile and Ile68Leu subjects had a late-onset cardiomyopathy (occurring after 55 years of age) and were more common in men. In contrast, Leu111Met subjects were significantly younger, and less likely to be male, in accordance with previous studies.<a href="#ehz173-B22" class="usa-link" aria-describedby="ehz173-B22"><sup>22</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B28" class="usa-link" aria-describedby="ehz173-B28"><sup>28</sup></a></p>
<p>This is important as, in most European countries, the diagnosis of ATTR-CM should be suspected in patients older than 55 years with hypertrophic cardiomyopathy phenotype. A recent prospective study including French patients with hypertrophic cardiomyopathy phenotype [median age (interquartile range): 62 (24) years] showed that 5% of patients, all aged &gt;63 and some &gt;80 years, had ATTR-CM, with Val122Ile the most common mutation (∼50% of patients).<a href="#ehz173-B29" class="usa-link" aria-describedby="ehz173-B29"><sup>29</sup></a> Similar studies have shown the high prevalence of ATTRwt in older European patients presenting with heart failure or hypertrophic cardiomyopathy.<a href="#ehz173-B30" class="usa-link" aria-describedby="ehz173-B30"><sup>30</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B31" class="usa-link" aria-describedby="ehz173-B31"><sup>31</sup></a> The THAOS registry, and these studies, highlight the need to perform <em>TTR</em> genetic studies in all patients with ATTR amyloidosis, whatever their age, to discriminate ATTRm and ATTRwt. Discovery of a <em>TTR</em> mutation, even in elderly patients, will have consequences for their families, so it is advised to perform a genetic test. It is difficult to otherwise rule out ATTR amyloidosis in patients younger than 55 years of age, particularly if they are from Denmark.</p></section><section id="sec18"><h3 class="pmc_sec_title">Cardiac phenotype of ATTR amyloidosis in continental Western Europe</h3>
<p>One-third of the subjects included in the THAOS registry in Europe have cardiac symptoms with a cardiac phenotype either with or without neurologic signs or symptoms. The cardiac phenotype in THAOS in Europe is mainly due to either ATTRwt or cardiac mutations (Leu111Met, Ile68Leu, and Val122Ile) but may also arise from other mutations (e.g. His88Arg<a href="#ehz173-B32" class="usa-link" aria-describedby="ehz173-B32"><sup>32</sup></a> or Val20Ile<a href="#ehz173-B33" class="usa-link" aria-describedby="ehz173-B33"><sup>33</sup></a>), with 17.4% of subjects in the ‘other mutations’ category having a cardiac phenotype.</p>
<p>The large majority of ATTRwt and cardiac mutations subjects in this analysis were male. This finding is consistent with previous studies showing ATTRwt is largely confined to elderly men,<a href="#ehz173-B34" class="usa-link" aria-describedby="ehz173-B34"><sup>34</sup></a> and that within ATTRm patients with cardiomyopathy there were fewer women and that those women tended to display considerably less severe morphological and functional echocardiographic impairment.<a href="#ehz173-B35" class="usa-link" aria-describedby="ehz173-B35"><sup>35</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B36" class="usa-link" aria-describedby="ehz173-B36"><sup>36</sup></a> This raises the possibility that some unexplained characteristic associated with the female sex protects against myocardial involvement in ATTR amyloidosis. Notably, ATTRwt may occur at an older age in women<a href="#ehz173-B37" class="usa-link" aria-describedby="ehz173-B37"><sup>37</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B38" class="usa-link" aria-describedby="ehz173-B38"><sup>38</sup></a> and, as a consequence, may be underdiagnosed in elderly women.</p>
<p>Subjects with a cardiac phenotype already showed heart failure symptoms and meaningful increase in LV wall thicknesses (showing the importance of cardiac infiltration of amyloid deposits) at the time of inclusion in THAOS, demonstrating that the diagnosis was made at a relatively late stage of disease. This emphasizes the need for earlier diagnosis, and for identifying early signs that can be shared with physicians (both general practitioners and cardiologists). As red flag, carpal tunnel syndrome is often the earliest presenting symptom and may precede cardiac symptoms by several years in subjects with ATTRwt and other cardiac mutations.<a href="#ehz173-B27" class="usa-link" aria-describedby="ehz173-B27"><sup>27–29</sup></a> The typical cardiac phenotype showed symmetric increase in LV and right ventricular wall thickness, especially in men aged ≥55 years with normal systolic blood pressure, valve thickening, and sparkling.<a href="#ehz173-B39" class="usa-link" aria-describedby="ehz173-B39"><sup>39</sup></a> It should be noted that, in this analysis, subjects with cardiac mutations were not exclusively associated with the cardiac phenotype, with 22.4% also having neurologic signs. This highlights that neuropathy needs to be diagnosed even in subjects with a cardiac genotype and is in accordance with a previous study in which ∼50% of patients diagnosed with a <em>TTR</em> cardiac mutation had a neuropathy.<a href="#ehz173-B29" class="usa-link" aria-describedby="ehz173-B29"><sup>29</sup></a> All these red flags should alert physicians to the possibility of ATTR amyloidosis, where the absence of restrictive filling pattern and low voltage should not rule out the suspicion.</p></section><section id="sec19"><h3 class="pmc_sec_title">Prognosis of ATTR amyloidosis in continental Western Europe</h3>
<p>In this analysis, there was a significantly poorer prognosis for subjects with cardiac mutations or ATTRwt. This observation is consistent with the differences in clinical measures and medical history between the genotype and phenotype categories and previous surveys of these patients. For example, subjects with ATTRwt and cardiac mutations had notably higher median levels of BNP, cardiac troponin T, and NTproBNP. A prior survey of cardiac biomarkers in subjects enrolled in THAOS identified higher plasma levels of BNP/NTproBNP as an independent predictor of survival.<a href="#ehz173-B40" class="usa-link" aria-describedby="ehz173-B40"><sup>40</sup></a> Together, these data should guide cardiologists in Europe, where the presence of symmetric LV hypertrophy and mildly depressed LVEF, especially in elderly men, should prompt the suspicion of ATTR amyloidosis if LV hypertrophy is unexplained.</p>
<p>There appeared to be some differences in treatment patterns between countries. For example, larger proportions of subjects on tafamidis (post-enrolment) were observed in Portugal (28.6%) and France (26.6%), which were predominately early-onset Val30Met; whereas, larger proportions of liver transplants were reported in Spain (43.4%). Notably, only 18.6 and 31.3% of all patients received a liver transplant or had ever received the disease modifying treatment tafamidis, respectively.</p></section><section id="sec20"><h3 class="pmc_sec_title">Limitations</h3>
<p>While this analysis demonstrated lower survival rates in subjects with cardiac disease, it was not designed to assess the relative contribution of specific factors other than phenotype and genotype group (controlled by age and sex). Other variables may also impact survival but are less likely to be as relevant for all the groups in this analysis. For example, cardiac measures may be relevant in patients with cardiac disease but not for patients with neurologic disease, while liver transplant status has been shown to have prognostic value for patients with the Val30Met mutation but less so for other mutations.<a href="#ehz173-B41" class="usa-link" aria-describedby="ehz173-B41"><sup>41</sup></a>
 <sup>,</sup>
 <a href="#ehz173-B42" class="usa-link" aria-describedby="ehz173-B42"><sup>42</sup></a> As THAOS is a large, international registry, there are inevitable variations in the clinical investigations and how complete the data, including data follow-up, are for each subject. While there are specific guidelines for the collection and reporting of data,<a href="#ehz173-B20" class="usa-link" aria-describedby="ehz173-B20"><sup>20</sup></a> the registry relies on assessments conducted in participating centres and there are no core data collection laboratories, so there may be variations in data availability and integrity. There are probably also non-random variations in missing data as, for example, cardiac symptoms in subjects with the neurologic phenotype may not be observed, or assessed, by the neurologist (and <em>vice versa</em>). Assignment of subjects to phenotype may also be imprecise as characterization of the cardiac phenotype was based on ECG and clinical data, which may not have been systematically obtained for subjects being treated by a neurologist. In this regard, selection of subjects included in the THAOS registry itself may be biased, as when it was established the majority of investigators were neurologists. While investigators of other specialties have since joined the registry, there remains an uneven distribution of specialties in some counties (<a href="#sup1" class="usa-link">Supplementary material online</a>, <em><a href="#sup1" class="usa-link">Table S1</a></em>) which may have influenced the distribution of subjects; most clearly in Denmark and Portugal, which had a strong correlation between the type of specialist and the phenotype of subjects. However, this was not evident in other countries and the large number of ‘other’ specialists, and subjects with a cardiac + neurologic phenotype, demonstrate that, overall, this correlation was not as strong as may have been expected. THAOS is a real-world registry so the proportion of neurologic, cardiologic, and ‘other specialty’ investigators will reflect the real distribution of where patients suspected to have ATTR amyloidosis are referred. With increased awareness among European cardiologists, it is likely that more ATTR-CM will be diagnosed.</p></section></section><section id="sec21"><h2 class="pmc_sec_title">Conclusion</h2>
<p>ATTR amyloidosis genotypes and phenotypes as observed in THAOS are highly heterogeneous in Europe. A geographic map of the different disease profiles and awareness that a subset of subjects have a dominant cardiac phenotype at presentation, mimicking hypertrophic cardiomyopathy, can facilitate the clinical recognition of this underdiagnosed disease.</p></section><section id="sec22"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="sup1"><div class="caption p"><span>ehz173_Supplementary_Data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8825236/bin/ehz173_supplementary_data.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (3.9MB, zip) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors thank all THAOS patients and investigators for their important contributions to this study. Medical writing support was provided by Joshua Fink, PhD, of Engage Scientific Solutions, and funded by Pfizer.</p>
<section id="sec23"><h3 class="pmc_sec_title">Funding</h3>
<p>This study was sponsored by Pfizer.</p>
<p>
<strong>Conflicts of interest:</strong> T.D. is a THAOS investigator and member of the THAOS Scientific Board; and has served as a medical advisor for Pfizer and received honoraria. His institution has received grant support from Pfizer; has served on the scientific advisory board of, and received funding from, Pfizer, Alnylam, Akcea, Prothena and GSK for scientific meeting expenses (travel, accommodation, and registration). A.V.K. is a THAOS investigator and member of the THAOS Scientific Board; and has served as a medical advisor for Pfizer and received honoraria for presentations. O.B.S. is a THAOS investigator and member of the THAOS Scientific Board; has received honoraria for presentation and funding from Pfizer for scientific meeting expenses (travel, accommodation, and registration); has served as member of advisory board for Alnylam and Prothena Pharmaceutical companies; and as a clinical investigator for Alnylam Pharmaceuticals. M.S.M. is a THAOS investigator and member of the THAOS Scientific Board; has received support from FoldRx Pharmaceuticals as a clinical investigator and for scientific meeting expenses; his institution has received grant support from Pfizer; has served on the scientific advisory board of and received funding from Pfizer for scientific meeting expenses (travel, accommodation, and registration). V.P.-B. is a THAOS investigator and member of the THAOS Scientific Board and has served as a medical advisor for Pfizer, Alnylam Pharmaceuticals, Eidos Therapeutics, and Ionis Inc. C.-R.Y. and M.-L.O. are employees of Pfizer and hold stock options with Pfizer. T.C. is a THAOS investigator and member of the THAOS Scientific Board; and has served as a medical advisor for Pfizer and received honoraria for presentations; and received funding from Pfizer for scientific meeting expenses (travel, accommodation, and registration). C.R. is a THAOS investigator and member of the THAOS Scientific Board; and has served as a medical advisor for Pfizer and received honoraria. His institution has received grant support from Pfizer; has served on the scientific advisory board of, and received funding from, Pfizer for scientific meeting expenses (travel, accommodation, and registration).</p></section></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Thibaud Damy, Referral Center for Cardiac Amyloidosis, Department of Cardiology, Mondor Amyloidosis Network, GRC Amyloid Research Institute, Clinical Investigation Center 006, DHU A-TVB INSERM U955 all at CHU Henri Mondor, UPEC, Créteil, France.</p>
<p>Arnt V Kristen, Department of Cardiology, Amyloidosis Center, Heidelberg University, Heidelberg, Germany.</p>
<p>Ole B Suhr, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.</p>
<p>Mathew S Maurer, Columbia University College of Physicians and Surgeons, New York, NY, USA.</p>
<p>Violaine Planté-Bordeneuve, Department of Neurology, Mondor Amyloid Network, Inserm U955-Team10, East Paris University Hospital Henri-Mondor, France.</p>
<p>Ching-Ray Yu, Pfizer Inc, New York, NY, USA.</p>
<p>Moh-Lim Ong, Pfizer Inc, New York, NY, USA.</p>
<p>Teresa Coelho, Department of Neurosciences, Hospital de Santo António, Centro Hospitalar do Porto, Porto, Portugal.</p>
<p>Claudio Rapezzi, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.</p></section><section id="ref1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="ehz173-B1">
<span class="label">1.</span><cite>

Plante-Bordeneuve  V, Said  G.
 Familial amyloid polyneuropathy. Lancet Neurol
 2011;10:1086–1097.</cite> [<a href="https://doi.org/10.1016/S1474-4422(11)70246-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22094129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Neurol&amp;title=Familial%20amyloid%20polyneuropathy&amp;volume=10&amp;publication_year=2011&amp;pages=1086-1097&amp;pmid=22094129&amp;doi=10.1016/S1474-4422(11)70246-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B2">
<span class="label">2.</span><cite>

Rapezzi  C, Quarta  CC, Riva  L, Longhi  S, Gallelli  I, Lorenzini  M, Ciliberti  P, Biagini  E, Salvi  F, Branzi  A.
 Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol
 2010;7:398–408.</cite> [<a href="https://doi.org/10.1038/nrcardio.2010.67" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20479782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cardiol&amp;title=Transthyretin-related%20amyloidoses%20and%20the%20heart:%20a%20clinical%20overview&amp;volume=7&amp;publication_year=2010&amp;pages=398-408&amp;pmid=20479782&amp;doi=10.1038/nrcardio.2010.67&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B3">
<span class="label">3.</span><cite>

Elliott  P, Andersson  B, Arbustini  E, Bilinska  Z, Cecchi  F, Charron  P, Dubourg  O, Kuhl  U, Maisch  B, McKenna  WJ, Monserrat  L, Pankuweit  S, Rapezzi  C, Seferovic  P, Tavazzi  L, Keren  A.
 Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J
 2008;29:270–276.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehm342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17916581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=Classification%20of%20the%20cardiomyopathies:%20a%20position%20statement%20from%20the%20European%20Society%20Of%20Cardiology%20Working%20Group%20on%20Myocardial%20and%20Pericardial%20Diseases&amp;volume=29&amp;publication_year=2008&amp;pages=270-276&amp;pmid=17916581&amp;doi=10.1093/eurheartj/ehm342&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B4">
<span class="label">4.</span><cite>

Buxbaum  JN, Tagoe  CE.
 The genetics of the amyloidoses. Annu Rev Med
 2000;51:543–569.</cite> [<a href="https://doi.org/10.1146/annurev.med.51.1.543" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10774481/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Med&amp;title=The%20genetics%20of%20the%20amyloidoses&amp;volume=51&amp;publication_year=2000&amp;pages=543-569&amp;pmid=10774481&amp;doi=10.1146/annurev.med.51.1.543&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B5">
<span class="label">5.</span><cite>

Connors  LH, Lim  A, Prokaeva  T, Roskens  VA, Costello  CE.
 Tabulation of human transthyretin (TTR) variants, 2003. Amyloid
 2003;10:160–184.</cite> [<a href="https://doi.org/10.3109/13506120308998998" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14640030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Tabulation%20of%20human%20transthyretin%20(TTR)%20variants,%202003&amp;volume=10&amp;publication_year=2003&amp;pages=160-184&amp;pmid=14640030&amp;doi=10.3109/13506120308998998&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B6">
<span class="label">6.</span><cite>

Rowczenio  DM, Noor  I, Gillmore  JD, Lachmann  HJ, Whelan  C, Hawkins  PN, Obici  L, Westermark  P, Grateau  G, Wechalekar  AD.
 Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat
 2014;35:E2403–E2412.</cite> [<a href="https://doi.org/10.1002/humu.22619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25044787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Online%20registry%20for%20mutations%20in%20hereditary%20amyloidosis%20including%20nomenclature%20recommendations&amp;volume=35&amp;publication_year=2014&amp;pages=E2403-E2412&amp;pmid=25044787&amp;doi=10.1002/humu.22619&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B7">
<span class="label">7.</span><cite>

Andrade  C.
 A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain
 1952;75:408–427.</cite> [<a href="https://doi.org/10.1093/brain/75.3.408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12978172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=A%20peculiar%20form%20of%20peripheral%20neuropathy;%20familiar%20atypical%20generalized%20amyloidosis%20with%20special%20involvement%20of%20the%20peripheral%20nerves&amp;volume=75&amp;publication_year=1952&amp;pages=408-427&amp;pmid=12978172&amp;doi=10.1093/brain/75.3.408&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B8">
<span class="label">8.</span><cite>

Parman  Y, Adams  D, Obici  L, Galan  L, Guergueltcheva  V, Suhr  OB, Coelho  T.
 Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol
 2016;29(Suppl 1):S3–S13.</cite> [<a href="https://doi.org/10.1097/WCO.0000000000000288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4739317/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26734951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Neurol&amp;title=Sixty%20years%20of%20transthyretin%20familial%20amyloid%20polyneuropathy%20(TTR-FAP)%20in%20Europe:%20where%20are%20we%20now?%20A%20European%20network%20approach%20to%20defining%20the%20epidemiology%20and%20management%20patterns%20for%20TTR-FAP&amp;volume=29&amp;publication_year=2016&amp;pages=S3-S13&amp;pmid=26734951&amp;doi=10.1097/WCO.0000000000000288&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B9">
<span class="label">9.</span><cite>

Carr  AS, Pelayo-Negro  AL, Evans  MR, Laura  M, Blake  J, Stancanelli  C, Iodice  V, Wechalekar  AD, Whelan  CJ, Gillmore  JD, Hawkins  PN, Reilly  MM.
 A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK. J Neurol Neurosurg Psychiatry
 2016;87:620–627.</cite> [<a href="https://doi.org/10.1136/jnnp-2015-310907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26243339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurol%20Neurosurg%20Psychiatry&amp;title=A%20study%20of%20the%20neuropathy%20associated%20with%20transthyretin%20amyloidosis%20(ATTR)%20in%20the%20UK&amp;volume=87&amp;publication_year=2016&amp;pages=620-627&amp;pmid=26243339&amp;doi=10.1136/jnnp-2015-310907&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B10">
<span class="label">10.</span><cite>

Rapezzi  C, Quarta  CC, Obici  L, Perfetto  F, Longhi  S, Salvi  F, Biagini  E, Lorenzini  M, Grigioni  F, Leone  O, Cappelli  F, Palladini  G, Rimessi  P, Ferlini  A, Arpesella  G, Pinna  AD, Merlini  G, Perlini  S.
 Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. Eur Heart J
 2013;34:520–528.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehs123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22745357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=Disease%20profile%20and%20differential%20diagnosis%20of%20hereditary%20transthyretin-related%20amyloidosis%20with%20exclusively%20cardiac%20phenotype:%20an%20Italian%20perspective&amp;volume=34&amp;publication_year=2013&amp;pages=520-528&amp;pmid=22745357&amp;doi=10.1093/eurheartj/ehs123&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B11">
<span class="label">11.</span><cite>

Hornsten  R, Pennlert  J, Wiklund  U, Lindqvist  P, Jensen  SM, Suhr  OB.
 Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid
 2010;17:63–68.</cite> [<a href="https://doi.org/10.3109/13506129.2010.483114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20462364/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Heart%20complications%20in%20familial%20transthyretin%20amyloidosis:%20impact%20of%20age%20and%20gender&amp;volume=17&amp;publication_year=2010&amp;pages=63-68&amp;pmid=20462364&amp;doi=10.3109/13506129.2010.483114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B12">
<span class="label">12.</span><cite>

Conceicao  I, De Carvalho  M.
 Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve
 2007;35:116–118.</cite> [<a href="https://doi.org/10.1002/mus.20644" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16969832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Muscle%20Nerve&amp;title=Clinical%20variability%20in%20type%20I%20familial%20amyloid%20polyneuropathy%20(Val30Met):%20comparison%20between%20late-%20and%20early-onset%20cases%20in%20Portugal&amp;volume=35&amp;publication_year=2007&amp;pages=116-118&amp;pmid=16969832&amp;doi=10.1002/mus.20644&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B13">
<span class="label">13.</span><cite>

Zaros  C, Genin  E, Hellman  U, Saporta  MA, Languille  L, Wadington-Cruz  M, Suhr  O, Misrahi  M, Planté-Bordeneuve  V.
 On the origin of the transthyretin Val30Met familial amyloid polyneuropathy. Ann Hum Genet
 2008;72:478–484.</cite> [<a href="https://doi.org/10.1111/j.1469-1809.2008.00439.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18460047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Hum%20Genet&amp;title=On%20the%20origin%20of%20the%20transthyretin%20Val30Met%20familial%20amyloid%20polyneuropathy&amp;volume=72&amp;publication_year=2008&amp;pages=478-484&amp;pmid=18460047&amp;doi=10.1111/j.1469-1809.2008.00439.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B14">
<span class="label">14.</span><cite>

Suhr  OB, Lundgren  E, Westermark  P.
 One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition. J Intern Med
 2017;281:337–347.</cite> [<a href="https://doi.org/10.1111/joim.12585" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28093848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Intern%20Med&amp;title=One%20mutation,%20two%20distinct%20disease%20variants:%20unravelling%20the%20impact%20of%20transthyretin%20amyloid%20fibril%20composition&amp;volume=281&amp;publication_year=2017&amp;pages=337-347&amp;pmid=28093848&amp;doi=10.1111/joim.12585&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B15">
<span class="label">15.</span><cite>

Castano  A, Drachman  BM, Judge  D, Maurer  MS.
 Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Fail Rev
 2015;20:163–178.</cite> [<a href="https://doi.org/10.1007/s10741-014-9462-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4361302/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25408161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Fail%20Rev&amp;title=Natural%20history%20and%20therapy%20of%20TTR-cardiac%20amyloidosis:%20emerging%20disease-modifying%20therapies%20from%20organ%20transplantation%20to%20stabilizer%20and%20silencer%20drugs&amp;volume=20&amp;publication_year=2015&amp;pages=163-178&amp;pmid=25408161&amp;doi=10.1007/s10741-014-9462-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B16">
<span class="label">16.</span><cite>

Elliott  PM, Anastasakis  A, Borger  MA, Borggrefe  M, Cecchi  F, Charron  P, Hagege  AA, Lafont  A, Limongelli  G, Mahrholdt  H, McKenna  WJ, Mogensen  J, Nihoyannopoulos  P, Nistri  S, Pieper  PG, Pieske  B, Rapezzi  C, Rutten  FH, Tillmanns  C, Watkins  H.
 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J
 2014;35:2733–2779.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehu284" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25173338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=2014%20ESC%20Guidelines%20on%20diagnosis%20and%20management%20of%20hypertrophic%20cardiomyopathy:%20the%20Task%20Force%20for%20the%20Diagnosis%20and%20Management%20of%20Hypertrophic%20Cardiomyopathy%20of%20the%20European%20Society%20of%20Cardiology%20(ESC)&amp;volume=35&amp;publication_year=2014&amp;pages=2733-2779&amp;pmid=25173338&amp;doi=10.1093/eurheartj/ehu284&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B17">
<span class="label">17.</span><cite>

Adams  D, Gonzalez-Duarte  A, O’Riordan  WD, Yang  C-C, Ueda  M, Kristen  AV, Tournev  I, Schmidt  HH, Coelho  T, Berk  JL, Lin  K-P, Vita  G, Attarian  S, Planté-Bordeneuve  V, Mezei  MM, Campistol  JM, Buades  J, Brannagan  TH, Kim  BJ, Oh  J, Parman  Y, Sekijima  Y, Hawkins  PN, Solomon  SD, Polydefkis  M, Dyck  PJ, Gandhi  PJ, Goyal  S, Chen  J, Strahs  AL, Nochur  SV, Sweetser  MT, Garg  PP, Vaishnaw  AK, Gollob  JA, Suhr  OB.
 Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med
 2018;379:11–21.</cite> [<a href="https://doi.org/10.1056/NEJMoa1716153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Patisiran,%20an%20RNAi%20therapeutic,%20for%20hereditary%20transthyretin%20amyloidosis&amp;volume=379&amp;publication_year=2018&amp;pages=11-21&amp;pmid=29972753&amp;doi=10.1056/NEJMoa1716153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B18">
<span class="label">18.</span><cite>

Benson  MD, Waddington-Cruz  M, Berk  JL, Polydefkis  M, Dyck  PJ, Wang  AK, Plante-Bordeneuve  V, Barroso  FA, Merlini  G, Obici  L, Scheinberg  M, Brannagan  TH
 3rd, Litchy  WJ, Whelan  C, Drachman  BM, Adams  D, Heitner  SB, Conceicao  I, Schmidt  HH, Vita  G, Campistol  JM, Gamez  J, Gorevic  PD, Gane  E, Shah  AM, Solomon  SD, Monia  BP, Hughes  SG, Kwoh  TJ, McEvoy  BW, Jung  SW, Baker  BF, Ackermann  EJ, Gertz  MA, Coelho  T.
 Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med
 2018;379:22–31.</cite> [<a href="https://doi.org/10.1056/NEJMoa1716793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12611561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Inotersen%20treatment%20for%20patients%20with%20hereditary%20transthyretin%20amyloidosis&amp;volume=379&amp;publication_year=2018&amp;pages=22-31&amp;pmid=29972757&amp;doi=10.1056/NEJMoa1716793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B19">
<span class="label">19.</span><cite>

Maurer  MS, Schwartz  JH, Gundapaneni  B, Elliott  PM, Merlini  G, Waddington Cruz  M, Kristen  AV, Grogan  DR, Witteles  R, Damy  T, Drachman  B, Shah  SJ, Hanna  M, Judge  DP, Barsdorf  AI, Huber  P, Patterson  TA, Riley  S, Schumacher  J, Stewart  M, Sultan  MB, Rapezzi  C; ATTR-ACT Study Investigators. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med
 2018;379:1007–1016.</cite> [<a href="https://doi.org/10.1056/NEJMoa1805689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30145929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=ATTR-ACT%20Study%20Investigators.%20Tafamidis%20treatment%20for%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy&amp;volume=379&amp;publication_year=2018&amp;pages=1007-1016&amp;pmid=30145929&amp;doi=10.1056/NEJMoa1805689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B20">
<span class="label">20.</span><cite>

Plante-Bordeneuve  V, Suhr  OB, Maurer  MS, White  B, Grogan  DR, Coelho  T.
 The transthyretin amyloidosis outcomes survey (THAOS) registry: design and methodology. Curr Med Res Opin
 2013;29:77–84.</cite> [<a href="https://doi.org/10.1185/03007995.2012.754349" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23193943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Med%20Res%20Opin&amp;title=The%20transthyretin%20amyloidosis%20outcomes%20survey%20(THAOS)%20registry:%20design%20and%20methodology&amp;volume=29&amp;publication_year=2013&amp;pages=77-84&amp;pmid=23193943&amp;doi=10.1185/03007995.2012.754349&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B21">
<span class="label">21.</span><cite>

Jacobson  DR, Alexander  AA, Tagoe  C, Buxbaum  JN.
 Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans. Amyloid
 2015;22:171–174.</cite> [<a href="https://doi.org/10.3109/13506129.2015.1051219" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26123279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Prevalence%20of%20the%20amyloidogenic%20transthyretin%20(TTR)%20V122I%20allele%20in%2014%20333%20African-Americans&amp;volume=22&amp;publication_year=2015&amp;pages=171-174&amp;pmid=26123279&amp;doi=10.3109/13506129.2015.1051219&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B22">
<span class="label">22.</span><cite>

Svendsen  IH, Steensgaard-Hansen  F, Nordvag  BY.
 A clinical, echocardiographic and genetic characterization of a Danish kindred with familial amyloid transthyretin methionine 111 linked cardiomyopathy. Eur Heart J
 1998;19:782–789.</cite> [<a href="https://doi.org/10.1053/euhj.1997.0841" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9717013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=A%20clinical,%20echocardiographic%20and%20genetic%20characterization%20of%20a%20Danish%20kindred%20with%20familial%20amyloid%20transthyretin%20methionine%20111%20linked%20cardiomyopathy&amp;volume=19&amp;publication_year=1998&amp;pages=782-789&amp;pmid=9717013&amp;doi=10.1053/euhj.1997.0841&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B23">
<span class="label">23.</span><cite>

Sattianayagam  PT, Hahn  AF, Whelan  CJ, Gibbs  SD, Pinney  JH, Stangou  AJ, Rowczenio  D, Pflugfelder  PW, Fox  Z, Lachmann  HJ, Wechalekar  AD, Hawkins  PN, Gillmore  JD.
 Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant. Eur Heart J
 2012;33:1120–1127.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehr383" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21992998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=Cardiac%20phenotype%20and%20clinical%20outcome%20of%20familial%20amyloid%20polyneuropathy%20associated%20with%20transthyretin%20alanine%2060%20variant&amp;volume=33&amp;publication_year=2012&amp;pages=1120-1127&amp;pmid=21992998&amp;doi=10.1093/eurheartj/ehr383&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B24">
<span class="label">24.</span><cite>

Almeida  MR, Hesse  A, Steinmetz  A, Maisch  B, Altland  K, Linke  RP, Gawinowicz  MA, Saraiva  MJ.
 Transthyretin Leu 68 in a form of cardiac amyloidosis. Basic Res Cardiol
 1991;86:567–571.</cite> [<a href="https://doi.org/10.1007/BF02190707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1786038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Basic%20Res%20Cardiol&amp;title=Transthyretin%20Leu%2068%20in%20a%20form%20of%20cardiac%20amyloidosis&amp;volume=86&amp;publication_year=1991&amp;pages=567-571&amp;pmid=1786038&amp;doi=10.1007/BF02190707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B25">
<span class="label">25.</span><cite>

Maurer  MS, Hanna  M, Grogan  M, Dispenzieri  A, Witteles  R, Drachman  B, Judge  DP, Lenihan  DJ, Gottlieb  SS, Shah  SJ, Steidley  DE, Ventura  H, Murali  S, Silver  MA, Jacoby  D, Fedson  S, Hummel  SL, Kristen  AV, Damy  T, Plante-Bordeneuve  V, Coelho  T, Mundayat  R, Suhr  OB, Waddington Cruz  M, Rapezzi  C.
 Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol
 2016;68:161–172.</cite> [<a href="https://doi.org/10.1016/j.jacc.2016.03.596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4940135/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27386769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Coll%20Cardiol&amp;title=Genotype%20and%20phenotype%20of%20transthyretin%20cardiac%20amyloidosis:%20THAOS%20(Transthyretin%20Amyloid%20Outcome%20Survey)&amp;volume=68&amp;publication_year=2016&amp;pages=161-172&amp;pmid=27386769&amp;doi=10.1016/j.jacc.2016.03.596&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B26">
<span class="label">26.</span><cite>

Reilly  MM, Staunton  H, Harding  AE.
 Familial amyloid polyneuropathy (TTR ala 60) in North West Ireland: a clinical, genetic, and epidemiological study. J Neurol Neurosurg Psychiatry
 1995;59:45–49.</cite> [<a href="https://doi.org/10.1136/jnnp.59.1.45" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1073600/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7608709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurol%20Neurosurg%20Psychiatry&amp;title=Familial%20amyloid%20polyneuropathy%20(TTR%20ala%2060)%20in%20North%20West%20Ireland:%20a%20clinical,%20genetic,%20and%20epidemiological%20study&amp;volume=59&amp;publication_year=1995&amp;pages=45-49&amp;pmid=7608709&amp;doi=10.1136/jnnp.59.1.45&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B27">
<span class="label">27.</span><cite>

Grogan  M, Scott  CG, Kyle  RA, Zeldenrust  SR, Gertz  MA, Lin  G, Klarich  KW, Miller  WL, Maleszewski  JJ, Dispenzieri  A.
 Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol
 2016;68:1014–1020.</cite> [<a href="https://doi.org/10.1016/j.jacc.2016.06.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27585505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Coll%20Cardiol&amp;title=Natural%20history%20of%20wild-type%20transthyretin%20cardiac%20amyloidosis%20and%20risk%20stratification%20using%20a%20novel%20staging%20system&amp;volume=68&amp;publication_year=2016&amp;pages=1014-1020&amp;pmid=27585505&amp;doi=10.1016/j.jacc.2016.06.033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B28">
<span class="label">28.</span><cite>

Suhr  OB, Svendsen  IH, Andersson  R, Danielsson  A, Holmgren  G, Ranlov  PJ.
 Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med
 2003;254:225–235.</cite> [<a href="https://doi.org/10.1046/j.1365-2796.2003.01173.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12930231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Intern%20Med&amp;title=Hereditary%20transthyretin%20amyloidosis%20from%20a%20Scandinavian%20perspective&amp;volume=254&amp;publication_year=2003&amp;pages=225-235&amp;pmid=12930231&amp;doi=10.1046/j.1365-2796.2003.01173.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B29">
<span class="label">29.</span><cite>

Damy  T, Costes  B, Hagège  AA, Donal  E, Eicher  J-C, Slama  M, Guellich  A, Rappeneau  S, Gueffet  J-P, Logeart  D, Planté-Bordeneuve  V, Bouvaist  H, Huttin  O, Mulak  G, Dubois-Randé  J-L, Goossens  M, Canoui-Poitrine  F, Buxbaum  JN.
 Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness. Eur Heart J
 2016;37:1826–1834.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehv583" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26537620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=Prevalence%20and%20clinical%20phenotype%20of%20hereditary%20transthyretin%20amyloid%20cardiomyopathy%20in%20patients%20with%20increased%20left%20ventricular%20wall%20thickness&amp;volume=37&amp;publication_year=2016&amp;pages=1826-1834&amp;pmid=26537620&amp;doi=10.1093/eurheartj/ehv583&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B30">
<span class="label">30.</span><cite>

Cariou  E, Bennani Smires  Y, Victor  G, Robin  G, Ribes  D, Pascal  P, Petermann  A, Fournier  P, Faguer  S, Roncalli  J, Rousseau  H, Chauveau  D, Carrie  D, Berry  I, Galinier  M, Lairez  O; Toulouse Amyloidosis Research Network Collaborators. Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis. Amyloid
 2017;24:101–109.</cite> [<a href="https://doi.org/10.1080/13506129.2017.1333956" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28553897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Diagnostic%20score%20for%20the%20detection%20of%20cardiac%20amyloidosis%20in%20patients%20with%20left%20ventricular%20hypertrophy%20and%20impact%20on%20prognosis&amp;volume=24&amp;publication_year=2017&amp;pages=101-109&amp;pmid=28553897&amp;doi=10.1080/13506129.2017.1333956&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B31">
<span class="label">31.</span><cite>

Gonzalez-Lopez  E, Gallego-Delgado  M, Guzzo-Merello  G, de Haro-Del Moral  FJ, Cobo-Marcos  M, Robles  C, Bornstein  B, Salas  C, Lara-Pezzi  E, Alonso-Pulpon  L, Garcia-Pavia  P.
 Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J
 2015;36:2585–2594.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehv338" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26224076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=Wild-type%20transthyretin%20amyloidosis%20as%20a%20cause%20of%20heart%20failure%20with%20preserved%20ejection%20fraction&amp;volume=36&amp;publication_year=2015&amp;pages=2585-2594&amp;pmid=26224076&amp;doi=10.1093/eurheartj/ehv338&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B32">
<span class="label">32.</span><cite>

Hellman  U, Lundgren  HE, Westermark  P, Stafberg  C, Nahi  H, Tachlinski  S, Guggi  M, Flogegard  M, Hamid  M, Escher  SA, Suhr  OB.
 A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family. Eur J Med Genet
 2015;58:211–215.</cite> [<a href="https://doi.org/10.1016/j.ejmg.2015.02.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25721874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Med%20Genet&amp;title=A%20genealogical%20and%20clinical%20study%20of%20the%20phenotypical%20variation%20within%20the%20Swedish%20transthyretin%20His88Arg%20(p.%20His108Arg)%20amyloidosis%20family&amp;volume=58&amp;publication_year=2015&amp;pages=211-215&amp;pmid=25721874&amp;doi=10.1016/j.ejmg.2015.02.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B33">
<span class="label">33.</span><cite>

Bauer  R, Dikow  N, Brauer  A, Kreuter  M, Buss  S, Evers  C, Rocken  C, Schnabel  PA, Hinderhofer  K, Ehlermann  P, Katus  HA, Kristen  AV.
 The “Wagshurst study”: P.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy. Amyloid
 2014;21:267–275.</cite> [<a href="https://doi.org/10.3109/13506129.2014.967846" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25291558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=The%20%E2%80%9CWagshurst%20study%E2%80%9D:%20P.Val40Ile%20transthyretin%20gene%20variant%20causes%20late-onset%20cardiomyopathy&amp;volume=21&amp;publication_year=2014&amp;pages=267-275&amp;pmid=25291558&amp;doi=10.3109/13506129.2014.967846&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B34">
<span class="label">34.</span><cite>

Rapezzi  C, Merlini  G, Quarta  CC, Riva  L, Longhi  S, Leone  O, Salvi  F, Ciliberti  P, Pastorelli  F, Biagini  E, Coccolo  F, Cooke  RM, Bacchi-Reggiani  L, Sangiorgi  D, Ferlini  A, Cavo  M, Zamagni  E, Fonte  ML, Palladini  G, Salinaro  F, Musca  F, Obici  L, Branzi  A, Perlini  S.
 Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation
 2009;120:1203–1212.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.108.843334" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19752327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Systemic%20cardiac%20amyloidoses:%20disease%20profiles%20and%20clinical%20courses%20of%20the%203%20main%20types&amp;volume=120&amp;publication_year=2009&amp;pages=1203-1212&amp;pmid=19752327&amp;doi=10.1161/CIRCULATIONAHA.108.843334&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B35">
<span class="label">35.</span><cite>

Rapezzi  C, Riva  L, Quarta  CC, Perugini  E, Salvi  F, Longhi  S, Ciliberti  P, Pastorelli  F, Biagini  E, Leone  O, Cooke  RM, Bacchi-Reggiani  L, Ferlini  A, Cavo  M, Merlini  G, Perlini  S, Pasquali  S, Branzi  A.
 Gender-related risk of myocardial involvement in systemic amyloidosis. Amyloid
 2008;15:40–48.</cite> [<a href="https://doi.org/10.1080/13506120701815373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18266120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Gender-related%20risk%20of%20myocardial%20involvement%20in%20systemic%20amyloidosis&amp;volume=15&amp;publication_year=2008&amp;pages=40-48&amp;pmid=18266120&amp;doi=10.1080/13506120701815373&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B36">
<span class="label">36.</span><cite>

Arvidsson  S, Pilebro  B, Westermark  P, Lindqvist  P, Suhr  OB.
 Amyloid cardiomyopathy in hereditary transthyretin V30M amyloidosis–impact of sex and amyloid fibril composition. PLoS One
 2015;10:e0143456..</cite> [<a href="https://doi.org/10.1371/journal.pone.0143456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4658178/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26600306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Amyloid%20cardiomyopathy%20in%20hereditary%20transthyretin%20V30M%20amyloidosis%E2%80%93impact%20of%20sex%20and%20amyloid%20fibril%20composition&amp;volume=10&amp;publication_year=2015&amp;pages=e0143456.&amp;pmid=26600306&amp;doi=10.1371/journal.pone.0143456&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B37">
<span class="label">37.</span><cite>

Lie  JT, Hammond  PI.
 Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc
 1988;63:552–564.</cite> [<a href="https://doi.org/10.1016/s0025-6196(12)64885-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3374172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mayo%20Clin%20Proc&amp;title=Pathology%20of%20the%20senescent%20heart:%20anatomic%20observations%20on%20237%20autopsy%20studies%20of%20patients%2090%20to%20105%20years%20old&amp;volume=63&amp;publication_year=1988&amp;pages=552-564&amp;pmid=3374172&amp;doi=10.1016/s0025-6196(12)64885-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B38">
<span class="label">38.</span><cite>

Mohammed  SF, Mirzoyev  SA, Edwards  WD, Dogan  A, Grogan  DR, Dunlay  SM, Roger  VL, Gertz  MA, Dispenzieri  A, Zeldenrust  SR, Redfield  MM.
 Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail
 2014;2:113–122.</cite> [<a href="https://doi.org/10.1016/j.jchf.2013.11.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3984539/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24720917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC%20Heart%20Fail&amp;title=Left%20ventricular%20amyloid%20deposition%20in%20patients%20with%20heart%20failure%20and%20preserved%20ejection%20fraction&amp;volume=2&amp;publication_year=2014&amp;pages=113-122&amp;pmid=24720917&amp;doi=10.1016/j.jchf.2013.11.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B39">
<span class="label">39.</span><cite>

Damy  T, Maurer  MS, Rapezzi  C, Plante-Bordeneuve  V, Karayal  ON, Mundayat  R, Suhr  OB, Kristen  AV.
 Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy. Open Heart
 2016;3:e000289..</cite> [<a href="https://doi.org/10.1136/openhrt-2015-000289" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4746524/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26870387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Open%20Heart&amp;title=Clinical,%20ECG%20and%20echocardiographic%20clues%20to%20the%20diagnosis%20of%20TTR-related%20cardiomyopathy&amp;volume=3&amp;publication_year=2016&amp;pages=e000289.&amp;pmid=26870387&amp;doi=10.1136/openhrt-2015-000289&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B40">
<span class="label">40.</span><cite>

Kristen  AV, Maurer  MS, Rapezzi  C, Mundayat  R, Suhr  OB, Damy  T.
 Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis–report from the Transthyretin Amyloidosis Outcome Survey (THAOS). PLoS One
 2017;12:e0173086..</cite> [<a href="https://doi.org/10.1371/journal.pone.0173086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5383030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28384285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Impact%20of%20genotype%20and%20phenotype%20on%20cardiac%20biomarkers%20in%20patients%20with%20transthyretin%20amyloidosis%E2%80%93report%20from%20the%20Transthyretin%20Amyloidosis%20Outcome%20Survey%20(THAOS)&amp;volume=12&amp;publication_year=2017&amp;pages=e0173086.&amp;pmid=28384285&amp;doi=10.1371/journal.pone.0173086&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B41">
<span class="label">41.</span><cite>

Ericzon  BG, Wilczek  HE, Larsson  M, Wijayatunga  P, Stangou  A, Pena  JR, Furtado  E, Barroso  E, Daniel  J, Samuel  D, Adam  R, Karam  V, Poterucha  J, Lewis  D, Ferraz-Neto  BH, Cruz  MW, Munar-Ques  M, Fabregat  J, Ikeda  S, Ando  Y, Heaton  N, Otto  G, Suhr  O.
 Liver transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative?
 Transplantation
 2015;99:1847–1854.</cite> [<a href="https://doi.org/10.1097/TP.0000000000000574" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26308415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transplantation&amp;title=Liver%20transplantation%20for%20hereditary%20transthyretin%20amyloidosis:%20after%2020%20years%20still%20the%20best%20therapeutic%20alternative?&amp;volume=99&amp;publication_year=2015&amp;pages=1847-1854&amp;pmid=26308415&amp;doi=10.1097/TP.0000000000000574&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ehz173-B42">
<span class="label">42.</span><cite>

Suhr  OB, Larsson  M, Ericzon  BG, Wilczek  HE.
 Survival after transplantation in patients with mutations other than Val30Met: extracts from the FAP World Transplant Registry. Transplantation
 2016;100:373–381.</cite> [<a href="https://doi.org/10.1097/TP.0000000000001021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4732012/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26656838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transplantation&amp;title=Survival%20after%20transplantation%20in%20patients%20with%20mutations%20other%20than%20Val30Met:%20extracts%20from%20the%20FAP%20World%20Transplant%20Registry&amp;volume=100&amp;publication_year=2016&amp;pages=373-381&amp;pmid=26656838&amp;doi=10.1097/TP.0000000000001021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>ehz173_Supplementary_Data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8825236/bin/ehz173_supplementary_data.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (3.9MB, zip) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from European Heart Journal are provided here courtesy of <strong>Oxford University Press</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1093/eurheartj/ehz173"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ehz173.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (523.9 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/8825236/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/8825236/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8825236%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8825236/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8825236/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC8825236/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/30938420/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC8825236/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/30938420/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC8825236/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/8825236/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="bf0JFnkjYileB5P2b4G3YPBMjzNa9qYncYNq88IvVEAKVy8npiLJMt3m4n3KM0F1">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
